View Scopus Subject Areas

Del Re, A C; Flückiger, Christoph (2016). Meta-analysis. In: Norcross, John C. APA handbook of clinical psychology: Theory and research (Vol. 2). Washington, DC: APA, 479-491.

Costa-Filho, R; Hochleitner, G; Wendt, M; Teruya, A; Spahn, D R (2016). Over 50 Years of Fibrinogen Concentrate. Clinical and Applied Thrombosis/Hemostasis, 22(2):109-114.

Gombotz, H; Zacharowski, K; Spahn, D R (2016). Patient Blood Management. Stuttgart, New York: Georg Thieme Verlag.

Weber, Damien C; Ares, Carmen; Albertini, Francesca; Frei-Welte, Martina; Niggli, Felix K; Schneider, Ralf; Lomax, Antony J (2016). Pencil beam scanning proton therapy for pediatric parameningeal rhabdomyosarcomas: Clinical outcome of patients treated at the Paul Scherrer Institute. Pediatric Blood & Cancer, 63(10):1731-1736.

Jessberger, Sebastian (2016). Stem Cell-Mediated Regeneration of the Adult Brain. Transfusion Medicine and Hemotherapy, 43(5):321-326.

Strasser, F; Blum, D; von Moos, R; Cathomas, R; Ribi, K; Aebi, S; Betticher, D; Hayoz, S; Klingbiel, D; Brauchli, P; Haefner, M; Mauri, S; Kaasa, S; Koeberle, D (2016). The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06). Annals of Oncology, 27(2):324-332.

Driessen, Christoph; Kraus, Marianne; Joerger, Markus; Rosing, Hilde; Bader, Jürgen; Hitz, Felicitas; Berset, Catherine; Xyrafas, Alexandros; Hawle, Hanne; Berthod, Gregoire; Overkleeft, Hermann S; Sessa, Cristiana; Huitema, Alwin; Pabst, Thomas; von Moos, Roger; Hess, Dagmar; Mey, Ulrich J M (2016). Treatment with the HIV protease inhibitor Nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08). Haematologica, 101(3):346-355.

2015

Harbort, C J; Soeiro-Pereira, Paulo Vitor; von Bernuth, Horst; Kaindl, Angela M; Costa-Carvalho, Beatriz Tavares; Condino-Neto, Antonio; Reichenbach, Janine; Roesler, Joachim; Zychlinsky, Arturo; Amulic, Borko (2015). Neutrophil oxidative burst activates ATM to regulate cytokine production and apoptosis. Blood, 126(26):2842-2851.

Brand, B; Dunn, S; Kulkarni, R (2015). Challenges in the management of haemophilia on transition from adolescence to adulthood. European Journal of Haematology, 95(S81):30-35.

Karow, Axel; Eekels, Julia J M; Zurbriggen, Karin; Schmid, Marlis; Schmugge, Markus; Speer, Oliver (2015). Hb G-Waimanalo [A1] [α64(E13)Asp→Asn; HBA1: c.193 G > A] with Decreased Oxygen Affinity. Hemoglobin, 39(6):432-434.

Frey, Pascal M; Méan, Marie; Limacher, Andreas; Jaeger, Kurt; Beer, Hans-Jürg; Frauchiger, Beat; Aschwanden, Markus; Rodondi, Nicolas; Righini, Marc; Egloff, Michael; Osterwalder, Joseph; Kucher, Nils; Angelillo-Scherrer, Anne; Husmann, Marc; Banyai, Martin; Matter, Christian M; Aujesky, Drahomir (2015). Physical activity and risk of bleeding in elderly patients taking anticoagulants. Journal of Thrombosis and Haemostasis, 13(2):197-205.

Kontny, Udo; Oschlies, Ilske; Woessmann, Willi; Burkhardt, Birgit; Lisfeld, Jasmin; Salzburg, Janina; Janda, Ales; Attarbaschi, Andishe; Niggli, Felix; Zimmermann, Martin; Reiter, Alfred; Klapper, Wolfram (2015). Non-anaplastic peripheral T-cell lymphoma in children and adolescents - a retrospective analysis of the NHL-BFM study group. British Journal of Haematology, 168(6):835-844.

Creutzig, U; Dworzak, M N; Zimmermann, M; Bourquin, J-P; Gruhn, B; Fleischhack, G; Graf, N; Klingebiel, T; Kremens, B; Lehrnbecher, T; von Neuhoff, C; Stackelberg, A V; Starý, J; Reinhardt, D (2015). Additional treatment with 2-Chloro-2-Deoxyadenosine during consolidation in children with high-risk acute myeloid leukemia does not improve survival. Leukemia, 29(11):2260-2263.

Moretti, D; Goede, J S; Zeder, C; Jiskra, M; Chatzinakou, V; Tjalsma, H; Melse-Boonstra, A; Brittenham, G; Swinkels, D W; Zimmermann, M B (2015). Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood, 126(17):1981-1989.

Nesteruk, Marta; Lang, Stephanie; Veit-Haibach, Patrick; Studer, Gabriela; Stieb, Sonja; Glatz, Stefan; Hemmatazad, Hossein; Ikenberg, Kristian; Huber, Gerhard; Pruschy, Martin; Guckenberger, Matthias; Klöck, Stephan; Riesterer, Oliver (2015). Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma. Radiotherapy and Oncology, 117(1):125-131.

Fischer, Kathelijn; Iorio, Alfonso; Lassila, Riitta; Peyvandi, Flora; Calizzani, Gabriele; Gatt, Alex; Lambert, Thierry; Windyga, Jerzy; Gilman, Estelle A; Makris, Michael (2015). Inhibitor development in non-severe haemophilia across Europe. Thrombosis and Haemostasis, 114(4):670-675.

Breymann, Christian (2015). Iron deficiency anemia in pregnancy. Seminars in Hematology, 52(4):339-347.

Dantonello, Tobias M; Stark, Monika; Timmermann, Beate; Fuchs, Jörg; Selle, Barbara; Linderkamp, Christin; Handgretinger, Rupert; Hagen, Rudolf; Feuchtgruber, Simone; Kube, Stefanie; Kosztyla, Daniel; Kazanowska, Bernarda; Ladenstein, Ruth; Niggli, Felix; Ljungman, Gustaf; Bielack, Stefan S; Klingebiel, Thomas; Koscielniak, Ewa (2015). Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma. Pediatric Blood & Cancer, 62(1):16-23.

Rook, Alain H; Gelfand, Joel C; Wysocka, Maria; Troxel, Andrea B; Benoit, Bernice; Surber, Christian; Elenitsas, Rosalie; Buchanan, Marie A; Leahy, Deborah S; Watanabe, Rei; Kirsch, Ilan R; Kim, Ellen J; Clark, Rachael A (2015). Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma. Blood, 126(12):1452-1461.

Thalhammer, Christoph; Alvarez, Elena; Husmann, Marc; Staub, Daniel; Kaspar, Mathias; Aschwanden, Markus; Amann-Vesti, Beatrice R (2015). Long term follow-up after endovascular brachytherapy of femoro-popliteal arteries. Clinical Hemorheology and Microcirculation, 61(2):251-257.

Dummer, R; Hauschild, A; Lindenblatt, N; Pentheroudakis, G; Keilholz, U (2015). Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Annals of Oncology, 26 Suppl:v126-v132.

Rodemann, H Peter; Bodis, Stephan (2015). Cutting-edge research in basic and translational radiation biology/oncology reflections from the 14th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology 2015. Radiotherapy and Oncology, 116(3):335-341.

Passweg, J R; Schanz, U; Chalandon, Y; Güngör, T; Baldomero, H; Heim, D; Nair, G; Medinger, M; Masouridi-Levrat, S; de Faveri, G N; Tiercy, J-M (2015). High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities. Bone Marrow Transplantation, 50(9):1201-1205.

Schandelmaier, S; Conen, K; von Elm, E; You, J J; et al; Schwenkglenks, Matthias (2015). Planning and reporting of quality-of-life outcomes in cancer trials. Annals of Oncology, 26(9):1966-1973.

Pentheroudakis, G; Cardoso, F; Arnold, D; Sessa, C; Peters, S; Horwich, A; Pavlidis, N; Stahel, R; Cervantes, A (2015). The ESMO guideline strategy: an identity statement and reflections on improvement. Annals of Oncology, 26 Suppl:v1-v7.

Fontana, Andrea O; Augsburger, Marc A; Grosse, Nicole; Guckenberger, Matthias; Lomax, Anthony J; Sartori, Alessandro A; Pruschy, Martin N (2015). Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation. Radiotherapy and Oncology, 116(3):374-380.

Mehra, Tarun; Seifert, Burkhardt; Bravo-Reiter, Silvina; Wanner, Guido; Dutkowski, Philipp; Holubec, Tomas; Moos, Rudolf M; Volbracht, Jörk; Manz, Markus G; Spahn, Donat R (2015). Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. Transfusion, 55(12):2807-2815.

Eberhardt, W E E; De Ruysscher, D; Weder, W; Le Péchoux, C; De Leyn, P; Hoffmann, H; Westeel, V; Stahel, R; Felip, E; Peters, S (2015). 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Annals of Oncology, 26(8):1573-1588.

Grube, Matthias; Brenmoehl, Julia; Rogler, Gerhard; Hahn, Joachim; Herr, Wolfgang; Holler, Ernst (2015). Donor Nucleotide-Binding Oligomerization-Containing Protein 2 (NOD2) Single Nucleotide Polymorphism 13 Is Associated with Septic Shock after Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 21(8):1399-404.

van Wezel, Esther M; Stutterheim, Janine; Vree, Florentien; Zappeij-Kannegieter, Lily; Decarolis, Boris; Hero, Barbara; Berthold, Frank; Schumacher-Kuckelkorn, Roswitha; Simon, Thorsten; Fiocco, Marta; Voermans, Carlijn; van Noesel, Max M; Caron, Huib N; van der Schoot, C Ellen; Tytgat, Godelieve A M (2015). Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma. Pediatric Blood & Cancer, 62(8):1368-1373.

Eckert, C; Hagedorn, N; Sramkova, L; Mann, G; Panzer-Grümayer, R; Peters, C; Bourquin, J-P; Klingebiel, T; Borkhardt, A; Cario, G; Alten, J; Escherich, G; Astrahantseff, K; Seeger, K; Henze, G; von Stackelberg, A (2015). Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment. Leukemia, 29(8):1648-1655.

Stahel, R A; Weder, W; Felley-Bosco, E; Petrausch, U; Curioni-Fontecedro, A; Schmitt-Opitz, I; Peters, S (2015). Searching for targets for the systemic therapy of mesothelioma. Annals of Oncology, 26(8):1649-1660.

Thomas, Lena; Lapa, Constatin; Bundschuh, Ralph Alexander; Polat, Bülent; Sonke, Jan-Jakob; Guckenberger, Matthias (2015). Tumour delineation in oesophageal cancer - A prospective study of delineation in PET and CT with and without endoscopically placed clip markers. Radiotherapy and Oncology, 116(2):269-275.

Bode, Sebastian F N; Ammann, Sandra; Al-Herz, Waleed; Bataneant, Mihaela; Dvorak, Christopher C; Gehring, Stephan; Gennery, Andrew; Gilmour, Kimberly C; Gonzalez-Granado, Luis I; Groß-Wieltsch, Ute; Ifversen, Marianne; Lingman-Framme, Jenny; Matthes-Martin, Susanne; Mesters, Rolf; Meyts, Isabelle; van Montfrans, Joris M; Pachlopnik Schmid, Jana; et al (2015). The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Haematologica, 100(7):978-988.

Bugarin, Cristina; Sarno, Jolanda; Palmi, Chiara; Savino, Angela Maria; te Kronnie, Geertruy; Dworzak, Michael; Shumich, Angela; Buldini, Barbara; Maglia, Oscar; Sala, Simona; Bronzini, Ilaria; Bourquin, Jean-Pierre; Mejstrikova, Ester; Hrusak, Ondrej; Luria, Drorit; Basso, Giuseppe; Izraeli, Shai; Biondi, Andrea; Cazzaniga, Giovanni; Gaipa, Giuseppe; I-BFM study group (2015). Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia. Haematologica, 100(6):e229-e232.

Frey, B M; Gassner, C; Jung, H H (2015). Neurodegeneration in the elderly - When the blood type matters: An overview of the McLeod syndrome with focus on hematological features. Transfusion and Apheresis Science, 52(3):277-284.

Borsig, Lubor (2015). vWF fibers induce thrombosis during cancer. Blood, 125(20):3042-3043.

Favero, F; McGranahan, N; Salm, M; Birkbak, N J; Sanborn, J Z; Benz, S C; Becq, J; Peden, J F; Kingsbury, Z; Grocok, R J; Humphray, S; Bentley, D; Spencer-Dene, B; Gutteridge, A; Brada, M; Roger, S; Dietrich, P-Y; Forshew, T; Gerlinger, M; Rowan, A; Stamp, G; Eklund, A C; Szallasi, Z; Swanton, C (2015). Glioblastoma adaptation traced through decline of an IDH1 clonal driver and macro-evolution of a double-minute chromosome. Annals of Oncology, 26(5):880-887.

Oldenburg, J; Aparicio, J; Beyer, J; Cohn-Cedermark, G; Cullen, M; Gilligan, T; De Giorgi, U; De Santis, M; de Wit, R; Fosså, S D; Germà-Lluch, J R; Gillessen, S; Haugnes, H S; Honecker, F; Horwich, A; Lorch, A; Ondruš, D; Rosti, G; Stephenson, A J; Tandstad, T (2015). Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer. Annals of Oncology, 26(5):833-838.

Wengenroth, L; Rueegg, C S; Michel, G; Gianinazzi, M E; Essig, S; von der Weid, N X; Grotzer, M; Kuehni, Claudia E (2015). Concentration, working speed and memory: cognitive problems in young childhood cancer survivors and their siblings. Pediatric Blood & Cancer, 62(5):875-882.

Azzouzi, Imane; Moest, Hansjoerg; Wollscheid, Bernd; Schmugge, Markus; Eekels, Julia J M; Speer, Oliver (2015). Deep sequencing and proteomic analysis of the microRNA-induced silencing complex in human red blood cells. Experimental Hematology, 43(5):382-392.

Vetsch, Janine; Rueegg, Corina S; Gianinazzi, Micòl E; Bergsträsser, Eva; von der Weid, Nicolas X; Michel, Gisela (2015). Information needs in parents of long-term childhood cancer survivors. Pediatric Blood & Cancer, 62(5):859-866.

Spirk, David; Nendaz, Mathieu; Aujesky, Drahomir; Hayoz, Daniel; Beer, Jürg H; Husmann, Marc; Frauchiger, Beat; Korte, Wolfgang; Wuillemin, Walter A; Righini, Marc; Bounameaux, Henri; Kucher, Nils (2015). Predictors of thromboprophylaxis in hospitalised medical patients. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE). Thrombosis and Haemostasis, 113(5):1127-1134.

Chowdary, P; Lethagen, S; Friedrich, U; Brand, B; Hay, C; Abdul Karim, F; Klamroth, R; Knoebl, P; Laffan, M; Mahlangu, J; Miesbach, W; Dalsgaard Nielsen, J; Martin-Salces, M; Angchaisuksiri, P (2015). Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. Journal of Thrombosis and Haemostasis, 13(5):743-754.

Dertschnig, Simone; Hauri-Hohl, Mathias M; Vollmer, Madeleine; Holländer, Georg A; Krenger, Werner (2015). Impaired thymic expression of tissue-restricted antigens licenses the de novo generation of autoreactive CD4+ T cells in acute GVHD. Blood, 125(17):2720-2723.

Dhedin, N; Huynh, A; Maury, S; Tabrizi, R; Beldjord, K; Asnafi, V; Thomas, X; Chevallier, P; Nguyen, S; Coiteux, V; Bourhis, J H; Hichri, Y; Escoffre-Barbe, M; Reman, O; Graux, C; Chalandon, Y; Blaise, D; Schanz, U; Lhéritier, V; Dombret, Hervé; Ifrah, N (2015). Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. Blood, 125(16):2486-2496.

Cseh, Annamaria; Niemeyer, Charlotte M; Yoshimi, Ayami; Dworzak, Michael; Hasle, Henrik; van den Heuvel-Eibrink, Marry M; Locatelli, Franco; Masetti, Riccardo; Schmugge, Markus; Groß-Wieltsch, Ute; Candás, Andrea; Kulozik, Andreas E; Olcay, Lale; Suttorp, Meinolf; Furlan, Ingrid; Strahm, Brigitte; Flotho, Christian (2015). Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood, 125(14):2311-2313.

Koeberle, D; Betticher, D C; von Moos, R; Dietrich, D; Brauchli, P; Baertschi, D; Matter, K; Winterhalder, R; Borner, M; Anchisi, S; Moosmann, P; Kollar, A; Saletti, P; Roth, A; Frueh, M; Kueng, M; Popescu, R A; Schacher, S; Hess, V; Herrmann, R (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology, 26(4):709-714.

Tucunduva, Luciana; Volt, Fernanda; Cunha, Renato; et al (2015). Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases. British Journal of Haematology, 169(1):103-110.

Vuille-Dit-Bille, Raphael N; Berger, Christoph; Meuli, Martin; Grotzer, Michael A (2015). Colostomy for perianal sepsis with ecthyma gangrenosum in immunocompromised children. Journal of Pediatric Hematology/Oncology:1-5.

Reinhart, Walter H; Piety, Nathaniel Z; Deuel, Jeremy W; Makhro, Asya; Schulzki, Thomas; Bogdanov, Nikolay; Goede, Jeroen S; Bogdanova, Anna; Abidi, Rajaa; Shevkoplyas, Sergey S (2015). Washing stored red blood cells in an albumin solution improves their morphologic and hemorheologic properties. Transfusion, 55(8):1872-1881.

Aalbers, Anna M; van den Heuvel-Eibrink, Marry M; Baumann, Irith; Dworzak, Michael; Hasle, Henrik; Locatelli, Franco; De Moerloose, Barbara; Schmugge, Markus; Mejstrikova, Ester; Nováková, Michaela; Zecca, Marco; Zwaan, C Michel; Te Marvelde, Jeroen G; Langerak, Anton W; van Dongen, Jacques J M; Pieters, Rob; Niemeyer, Charlotte M; van der Velden, Vincent H J (2015). Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood. Haematologica, 100(3):315-323.

Spahn, Donat R; Spahn, Gabriela H; Stein, Philipp (2015). Evidence base for restrictive transfusion triggers in high-risk patients. Transfusion Medicine and Hemotherapy, 42(2):110-114.

Schlenke, Peter; Spahn, Donat R (2015). Patient Blood Management: it is time to streamline targeted therapy options. Transfusion Medicine and Hemotherapy, 42(2):72-73.

Peulen, Heike; Belderbos, José; Guckenberger, Matthias; Hope, Andrew; Grills, Inga; van Herk, Marcel; Sonke, Jan-Jakob (2015). Target delineation variability and corresponding margins of peripheral early stage NSCLC treated with stereotactic body radiotherapy. Radiotherapy and Oncology, 114(3):361-366.

Gelderman, Monique P; Baek, Jin Hyen; Yalamanoglu, Ayla; Puglia, Michele; Vallelian, Florence; Burla, Bo; Vostal, Jaroslav; Schaer, Dominik J; Buehler, Paul W (2015). Reversal of hemochromatosis by apo-transferrin in non-transfused and transfused Hbbth3/+ (heterozygous b1/ b2 globin gene deletion) mice. Haematologica, 100(5):611-622.

Lüscher, T F; Steffel, J (2015). Individualized antithrombotic therapy. Hämostaseologie, 36(1):26-32.

Reiner, M F; Martinod, K; Stivala, S; Savarese, G; Camici, G G; Lüscher, T F; Wagner, D D; Beer, J H (2015). Dietary omega-3 alpha-linolenic acid does not prevent venous thrombosis in mice. Thrombosis and Haemostasis, 113(1):177-184.

Gross, Irwin; Seifert, Burkhardt; Hofmann, Axel; Spahn, Donat R (2015). Patient blood management in cardiac surgery results in fewer transfusions and better outcome. Transfusion, 55(5):1075-1081.

Niemeyer, Charlotte M; Loh, Mignon L; Cseh, Annamaria; Cooper, Todd; Dvorak, Christopher C; Chan, Rebecca; Xicoy, Blanca; Germing, Ulrich; Kojima, Seiji; Manabe, Atsushi; Dworzak, Michael; De Moerloose, Barbara; Starý, Jan; Smith, Owen P; Masetti, Riccardo; Catala, Albert; Bergstraesser, Eva; Ussowicz, Marek; Fabri, Oskana; Baruchel, André; Cavé, Hélène; Zwaan, Michel; Locatelli, Franco; Hasle, Henrik; van den Heuvel-Eibrink, Marry M; Flotho, Christian; Yoshimi, Ayami (2015). Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia. Haematologica, 100(1):17-22.

Theocharides, A P; Dobson, S M; Laurenti, E; Notta, F; Voisin, V; Cheng, P Y; Yuan, J S; Guidos, C J; Minden, M D; Mullighan, C G; Torlakovic, E; Dick, J E (2015). Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts. Leukemia, 29(1):177-187.

Santagostino, E; Lentz, S R; Misgav, M; Brand, B; Chowdary, P; Savic, A; Kilinc, Y; Amit, Y; Amendola, A; Solimeno, L P; Saugstrup, T; Matytsina, I (2015). Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials. Haemophilia, 21(1):34-40.

Blumenthal, Deborah T; Rankin, Cathryn; Stelzer, Keith J; Spence, Alexander M; Sloan, Andrew E; Moore, Dennis F; Padula, Gilbert D A; Schulman, Susan B; Wade, Mark L; Rushing, Elisabeth J (2015). A Phase III study of radiation therapy (RT) and O6-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001. International Journal of Clinical Oncology, 20(4):650-658.

Rechsteiner, M; Wild, P; Kiessling, M K; Bohnert, A; Zhong, Q; Stahel, R A; Moch, H; Curioni-Fontecedro, A (2015). A novel germline mutation of PDGFR-β might be associated with clinical response of colorectal cancer to regorafenib. Annals of Oncology, 26(1):246-248.

Fahrni, Jennifer; Husmann, M; Gretener, S B; Keo, H H (2015). Assessing the risk of recurrent venous thromboembolism - practical approach. Vascular Health and Risk Management, 2015(11):451-459.

Sandrock-Lang, K; Oldenburg, J; Wiegering, V; Halimeh, S; Santoso, S; Kurnik, K; Fischer, L; Tsakiris, D A; Sigl-Kraetzig, M; Brand, B; Bührlen, M; Kraetzer, K; Deeg, N; Hund, M; Busse, E; Kahle, A; Zieger, B (2015). Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations. Thrombosis and Haemostasis, 113(4):782-791.

Curioni-Fontecedro, Alessandra; Martin, Vittoria; Vogetseder, Alexander; Knuth, Alexander; Moch, Holger; Soldini, Davide; Tinguely, Marianne (2015). Chromosomal aberrations of cancer-testis antigens in myeloma patients. Hematological oncology, 33(3):159-163.

Cornelissen, J J; Versluis, J; Passweg, J R; van Putten, W L; Manz, M G; Maertens, J; Beverloo, H B; Valk, P J; van Marwijk, Kooy M; Wijermans, P W; Schaafsma, M R; Biemond, B J; Vekemans, M C; Breems, D A; Verdonck, L F; Fey, M F; Jongen-Lavrencic, M; Janssen, J J; Huls, G; Kuball, J; Pabst, T; Graux, C; Schouten, H C; Gratwohl, A; Vellenga, E; Ossenkoppele, G; Löwenberg, B (2015). Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia, 29(5):1041-1050.

Gemuenden, Cornelia; Benz, Rudolf; Senn, Oliver; Goede, Jeroen S; Manz, Markus G; Gerber, Bernhard (2015). Efficacy of Azacitidine in de Novo and relapsed acute Myeloid Leukemia: A retrospective comparative study. Clinical Lymphoma, Myeloma & Leukemia, 15(12):811-815.

Samaras, Panagiotis; Pfrommer, Sarah; Seifert, Burkhardt; Petrausch, Ulf; Mischo, Axel; Schmidt, Adrian; Schanz, Urs; Nair, Gayathri; Bargetzi, Mario; Taverna, Christian; Stupp, Roger; Stenner-Liewen, Frank; Renner, Christoph (2015). Efficacy of vinorelbine plus G-CSF for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma. Biology of Blood and Marrow Transplantation, 21(1):74-80.

Maxwell, Perry; Melendez-Rodríguez, Florinda; Matchett, Kyle B; Thiersch, Markus; Schneider Gasser, Edith M; Gassmann, Max; et al (2015). Novel antibodies directed against the human erythropoietin receptor: Creating a basis for clinical implementation. British Journal of Haematology, 168(3):429-442.

Auerbach, M; Adamson, J; Bircher, A; Breymann, C; Fishbane, S; Gafter-Gvili, A; Gasche, C; Gilreath, J; Grazzini, G; Henry, D; Liumbruno, G; Locatelli, F; Macdougall, I; Munoz, M; Rampton, D; Rodgers, G; Shander, A (2015). On the safety of intravenous iron, evidence trumps conjecture. Haematologica, 100(5):e214-e215.

Theusinger, Oliver M; Stein, Philipp; Levy, Jerrold H (2015). Point of care and factor concentrate-based coagulation algorithms. Transfusion Medicine and Hemotherapy:115-121.

Kreher, S; Strehlow, F; Martus, P; Roth, P; Hertenstein, B; Röth, A; Birnbaum, T; Griesinger, F; Rauch, M; Kanz, L; Thiel, E; Weller, M; Korfel, A (2015). Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial. Annals of Hematology, 94(3):409-414.

Hecht, M; Zimmer, L; Loquai, C; et al; Goldinger, S M (2015). Radiosensitization by BRAF inhibitor therapy--mechanism and frequency of toxicity in melanoma patients. Annals of Oncology, 26(6):1238-1244.

Dahele, Max; Hatton, Matthew; Slotman, Ben; Guckenberger, Matthias (2015). Stereotactic body radiotherapy: A survey of contemporary practice in six selected European countries. Acta Oncologica, 54(8):1237-1241.

Pfeil, Alena M; Imfeld, Patrick; Pettengell, Ruth; Jick, Susan S; Szucs, Thomas D; Meier, Christoph R; Schwenkglenks, Matthias (2015). Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD). Annals of Hematology, 94(3):421-429.

Fujii, K; Karpova, M B; Asagoe, K; Georgiev, O; Dummer, R; Urosevic-Maiwald, M (2015). Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy. Leukemia, 29(10):2024-2032.

2014

Kerlin, B; Brand, B; Inbal, A; Halimeh, S; Nugent, D; Lundblad, M; Tehranchi, R (2014). Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency. Journal of Thrombosis and Haemostasis, 12(12):2038-2043.

Holy, Erik W; Besler, Christian; Reiner, Martin F; Camici, Giovanni G; Manz, Jasmin; Beer, Jürg H; Lüscher, Thomas F; Landmesser, Ulf; Tanner, Felix C (2014). High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: Impact on arterial thrombus formation. Thrombosis and Haemostasis, 112(5):1024-1035.

Waespe, Nicolas; Zeilhofer, Ulrike B; Güngör, Tayfun (2014). Treatment-refractory multi-lineage autoimmune cytopenia after unrelated cord blood transplantation: remission after combined bortezomib and vincristine treatment. Pediatric Blood & Cancer, 61(11):2112-2114.

Schwinger, Wolfgang; Sovinz, Petra; Benesch, Martin; Lackner, Herwig; Seidel, Markus; Strenger, Volker; Sperl, Daniela; Raicht, Andrea; Brunner-Krainz, Michaela; Paschke, Eduard; Plecko, Barbara; Urban, Christian (2014). Unrelated CD3/CD19-depleted peripheral stem cell transplantation for Hurler syndrome. Pediatric Hematology and Oncology, 31(8):723-730.

Kübler, Ayline; Woiterski, Jeanette; Witte, Kai-Erik; Bühring, Hans-Jörg; Hartwig, Udo F; Ebinger, Martin; Oevermann, Lena; Mezger, Markus; Herr, Wolfgang; Lang, Peter; Handgretinger, Rupert; Münz, Christian; André, Maya C (2014). Both mature KIR+ and immature KIR- NK cells control pediatric acute B cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz mice. Blood, 124(26):3914-3923.

Azzi, Tarik; Lünemann, Anna; Murer, Anita; Ueda, Seigo; Béziat, Vivien; Malmberg, Karl-Johan; Staubli, Georg; Gysin, Claudine; Berger, Christoph; Münz, Christian; Chijioke, Obinna; Nadal, David (2014). Role for early-differentiated natural killer cells in infectious mononucleosis. Blood, 124(16):2533-2543.

Braig, M; Pällmann, N; Preukschas, M; Steinemann, D; Hofmann, W; Gompf, A; Streichert, T; Braunschweig, T; Copland, M; Rudolph, K L; Bokemeyer, C; Koschmieder, S; Schuppert, A; Balabanov, S; Brümmendorf, T H (2014). A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells. Leukemia, 28(10):2028-2039.

Biswas, A; Ivaskevicius, V; Thomas, A; Varvenne, M; Brand, B; Rott, H; Haussels, I; Ruehl, H; Scholz, Ute; Klamroth, R; Oldenburg, J (2014). Eight novel F13A1 gene missense mutations in patients with mild FXIII deficiency: in silico analysis suggests changes in FXIII-A subunit structure/function. Annals of Hematology, 93(10):1665-1676.

Florek, M; Sega, E I; Leveson-Gower, D B; Baker, J; Müller, A M S; Schneidawind, D; Meyer, E; Negrin, R S (2014). Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models. Blood, 124(11):1832-1842.

von Känel, Roland; Meister, Rebecca E; Stutz, Monika; Kummer, Petra; Arpagaus, Angela; Huber, Susanne; Ehlert, Ulrike; Wirtz, Petra H (2014). Effects of dark chocolate consumption on the prothrombotic response to acute psychosocial stress in healthy men. Thrombosis and Haemostasis, 112(6):1151-1158.

Kirsch, M; Götz, A; Halter, J P; Schanz, U; Stussi, G; Dobbels, F; De Geest, S (2014). Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study. Bone Marrow Transplantation, 49(9):1223-1230.

Dummer, R; Duvic, M; Scarisbrick, J; Olsen, E A; Rozati, S; Eggmann, N; Goldinger, S M; Hutchinson, K; Geskin, L; Illidge, T M; Giuliano, E; Elder, J; Kim, Y H (2014). Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Annals of Oncology, 25(9):1807-1812.

Popescu, R; Ciardiello, F; Stahel, R (2014). Reply to the letter to the editor 'Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper' by Valentini et al. Annals of Oncology, 25(9):1865.

Soldini, Davide; Georgis, Antoin; Montagna, Chiara; Schüffler, Peter Johannes; Martin, Vittoria; Curioni-Fontecedro, Alessandra; Martinez, Antonio; Tinguely, Marianne (2014). The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas. Hematological oncology, 32(3):120-125.

Boettcher, S; Gerosa, R C; Radpour, R; Bauer, J; Ampenberger, F; Heikenwalder, M; Kopf, M; Manz, M G (2014). Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis. Blood, 124(9):1393-1403.

Bourquin, Jean-Pierre (2014). The clinical path to integrated genomics in ALL. Blood, 124(9):1380-1381.

Hänggi, Pascal; Makhro, Asya; Gassmann, Max; Schmugge, Markus; Goede, Jeroen S; Speer, Oliver; Bogdanova, Anna (2014). Red blood cells of sickle cell disease patients exhibit abnormally high abundance of N-methyl D-aspartate receptors mediating excessive calcium uptake. British Journal of Haematology, 167(2):252-264.

Beyer, Jörg (2014). Miracles don`t happen any more. Annals of Oncology, 25(9):1679-1680.

Urner-Bloch, U; Urner, M; Stieger, P; Galliker, N; Winterton, N; Zubel, A; Moutouh-de Parseval, L; Dummer, R; Goldinger, S M (2014). Transient MEK inhibitor-associated retinopathy in metastatic melanoma. Annals of Oncology, 25(7):1437-1441.

Ciardiello, F; Arnold, D; Casali, P G; Cervantes, A; Douillard, J-Y; Eggermont, A; Eniu, A; McGregor, K; Peters, S; Piccart, M; Popescu, R; Van Cutsem, E; Zielinski, C; Stahel, R (2014). Delivering Precision Medicine in Oncology Today and in Future-The Promise and Challenges of Personalised Cancer Medicine: a position paper by the European Society for Medical Oncology (ESMO). Annals of Oncology, 25(9):1673-1678.

Benz, R; Gerber, B (2014). Lots of clots and rods. British Journal of Haematology, 165(6):744-?.

Nair, Nisha; Rincon, Melvin Y; Evens, Hanneke; Sarcar, Shilpita; Dastidar, Sumitava; Samara-Kuko, Emira; Ghandeharian, Omid; Man Viecelli, Hiu; Thöny, Beat; De Bleser, Pieter; VandenDriessche, Thierry; Chuah, Marinee K (2014). Computationally designed liver-specific transcriptional modules and hyperactive factor IX improve hepatic gene therapy. Blood, 123(20):3195-3199.

Besse, B; Adjei, A; Baas, P; Meldgaard, P; Nicolson, M; Paz-Ares, L; Reck, M; Smit, E F; Syrigos, K; Stahel, R; Felip, E; Peters, S (2014). 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease. Annals of Oncology, 25(8):1475-1484.

Vansteenkiste, J; Crinò, L; Dooms, C; Douillard, J Y; Faivre-Finn, C; Lim, E; Rocco, G; Senan, S; Van Schil, P; Veronesi, G; Stahel, R; Peters, S; Felip, E (2014). 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Annals of Oncology, 25(8):1462-1474.

Storey, Robert F; Kotha, Jayaprakash; Smyth, Susan S; Moliterno, David J; Rorick, Tyrus L; Moccetti, Tiziano; Valgimigli, Marco; Dery, Jean Pierre; Cornel, Jan H; Thomas, Gregory S; Huber, Kurt; Harrington, Robert A; Hord, Edward; Judge, Heather M; Chen, Edmond; Strony, John; Mahaffey, Kenneth W; Tricoci, Pierluigi; Becker, Richard C; Jennings, Lisa K (2014). Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy. Thrombosis and Haemostasis, 111(5):883-891.

Müller, Antonia M S; Poyser, J; Küpper, N J; Burnett, C; Ko, R M; Kohrt, H E K; Florek, M; Zhang, P; Negrin, R S (2014). Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment. Blood, 123(18):2882-2892.

Schlesinger, Martin; Roblek, Marko; Ortmann, Katrin; Naggi, A; Torri, G; Borsig, L; Bendas, Gerd (2014). The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin. Thrombosis Research, 133(5):855-862.

Wong, W Wei-Lynn; Vince, James E; Lalaoui, Najoua; Lawlor, Kate E; Chau, Diep; Bankovacki, Aleksandra; Anderton, Holly; Metcalf, Donald; O'Reilly, Lorraine; Jost, Philipp J; Murphy, James M; Alexander, Warren S; Strasser, Andreas; Vaux, David L; Silke, John (2014). cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner. Blood, 123(16):2562-2572.

Kerr, K M; Bubendorf, L; Edelman, M J; Marchetti, A; Mok, T; Novello, S; O'Byrne, K; Stahel, R; Peters, S; Felip, E (2014). Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Annals of Oncology, 25(9):1681-1690.

Yoshimi, Ayami; van den Heuvel-Eibrink, Marry M; Baumann, Irith; Schwarz, Stephan; Simonitsch-Klupp, Ingrid; de Paepe, Pascale; Campr, Vit; Kerndrup, Gitte Birk; O'Sullivan, Maureen; Devito, Rita; Leguit, Roos; Hernandez, Miguel; Dworzak, Michael; de Moerloose, Barbara; Stary, Jan; Hasle, Henrik; Smith, Owen P; Zecca, Marco; Catala, Albert; Schmugge, Markus; Locatelli, Franco; Führer, Monika; Fischer, Alexandra; Guderle, Anne; Nöllke, Peter; Strahm, Brigitte; Niemeyer, Charlotte M (2014). Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood. Haematologica, 99(4):656-63.

Schilling, B; Sondermann, W; Zhao, F; Griewank, K G; Livingstone, E; Sucker, A; Zelba, H; Weide, B; Trefzer, U; Wilhelm, T; Loquai, C; Berking, C; Hassel, J; Kähler, K C; Utikal, J; Al Ghazal, P; Gutzmer, R; Goldinger, S M; Zimmer, L; Paschen, A; Hillen, U; Schadendorf, D; Dermatologic Cooperative Oncology Group (2014). Differential influence of vemurafenib and dabrafenib on patients’ lymphocytes despite similar clinical efficacy in melanoma. Annals of Oncology, 25(3):747-753.

Kestin, L; Grills, I; Guckenberger, M; Belderbos, J; Hope, A J; Werner-Wasik, M; Sonke, J J; Bissonnette, J P; Xiao, Y; Yan, D (2014). Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance. Radiotherapy and Oncology, 110(3):499-504.

Wengenroth, L; Rueegg, C S; Michel, G; Essig, S; Ammann, R A; Bergstraesser, E; Kuehni, C E (2014). Life partnerships in childhood cancer survivors, their siblings, and the general population. Pediatric Blood & Cancer, 61(3):538-545.

Bakchoul, Tamam; Bassler, Dirk; Heckmann, Matthias; Thiele, Thomas; Kiefel, Volker; Gross, Isabel; Arnold, Donald M; DiTomasso, Julie; Smith, James W; Paes, Bosco; Greinacher, Andreas (2014). Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin. Transfusion, 54(3):640-645.

Muroi, C; Fujioka, M; Mishima, K; Irie, K; Fujimura, Y; Nakano, T; Fandino, J; Keller, E; Iwasaki, K; Fujiwara, M (2014). Effect of ADAMTS-13 on cerebrovascular microthrombosis and neuronal injury after experimental subarachnoid hemorrhage. Journal of Thrombosis and Haemostasis, 12(4):505-514.

Aalbers, A M; van der Velden, V H J; Yoshimi, A; Fischer, A; Noellke, P; Zwaan, C M; Baumann, I; Beverloo, H B; Dworzak, M; Hasle, H; Locatelli, F; De Moerloose, B; Göhring, G; Schmugge, M; Stary, J; Zecca, M; Langerak, A W; van Dongen, J J M; Pieters, R; Niemeyer, C M; van den Heuvel-Eibrink, M M (2014). The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS. Leukemia, 28(1):189-92.

Popescu, R A; Schäfer, R; Califano, R; Eckert, R; Coleman, R; Douillard, J-Y; Cervantes, A; Casali, P G; Sessa, C; Van Cutsem, E; de Vries, E; Pavlidis, N; Fumasoli, K; Wörmann, B; Samonigg, H; Cascinu, S; Cruz Hernández, J J; Howard, A J; Ciardiello, F; Stahel, R A; Piccart, M (2014). The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO). Annals of Oncology, 25(1):9-15.

Montagna, Chiara. A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome. 2014, University of Zurich, Faculty of Medicine.

Storti, Federica; Santambrogio, Sara; et al (2014). A novel distal upstream hypoxia response element regulating oxygen-dependent erythropoietin gene expression. Haematologica, 99(4):e45-e48.

Tonder, Michaela; Eisele, Günter; Weiss, Tobias; Hofer, Silvia; Seystahl, Katharina; Valavanis, Antonios; Stupp, Roger; Weller, Michael; Roth, Patrick (2014). Addition of lomustine for bevacizumab-refractory recurrent glioblastoma. Acta Oncologica, 53(10):1436-1440.

Harrison, C J; Bourquin, Jean-Pierre; et al (2014). An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. Leukemia, 28(5):1015-1021.

Jakovljevic, Mihajlo; Gutzwiller, Florian; Schwenkglenks, Matthias; Milovanovic, Olivera; Rancic, Nemanja; Varjacic, Mirjana; Stojadinovic, Dobrivoje; Dagovic, Aleksandar; Matter-Walstra, Klazien (2014). Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma. Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 19(4):1111-1120.

Knöfler, R; Eberl, W; Schulze, H; Bakchoul, T; Bergmann, F; Gehrisch, S; Geisen, C; Gottstein, S; Halimeh, S; Harbrecht, U; Kappert, G; Kirchmaier, C; Kehrel, B; Lösche, W; Krause, M; Mahnel, R; Meyer, O; Pilgrimm, A K; Pillitteri, D; Rott, H; Santoso, S; Siegemund, A; Schambeck, C; Scheer, M; Schmugge, M; Scholl, T; Strauss, G; Zieger, B; Zotz, R; Hermann, M; Streif, W (2014). Diagnose angeborener Störungen der Thrombozytenfunktion Interdisziplinäre S2K-Leitlinie der Ständigen Kommission Pädiatrie der Gesellschaft für Thrombose- und Hämostaseforschung e. V. Hämostaseologie, 34(3):201-212.

Comazzi, St; Guscetti, Franco; Marconato, L (2014). First meeting of the European canine lymphoma group. Workshop: state of the art and comparative aspects in canine lymphoma. CH-Lugano, 22 June 2013. Hematological oncology, 32(2):68-71.

Schadendorf, D; Amonkar, M M; Milhem, M; Grotzinger, K; Demidov, L V; Rutkowski, P; Garbe, C; Dummer, R; Hassel, J C; Wolter, P; Mohr, P; Trefzer, U; Lefeuvre-Plesse, C; Rutten, A; Steven, N; Ullenhag, G; Sherman, L; Wu, F S; Patel, K; Casey, M; Robert, C (2014). Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study. Annals of Oncology, 25(3):700-706.

Stankov, M V; Bourquin, J P; et al (2014). Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy. Leukemia, 28(3):577-588.

Tinguely, Marianne; Thies, Svenja; Frigerio, Simona; Reineke, Tanja; Korol, Dimitri; Zimmermann, Dieter R (2014). IRF8 is associated with a GCB-type of DLBCL and exceptionally involved in a translocation t(14;16) (q32.33;q24.1). Leukemia & Lymphoma, 55(1):136-142.

Palladini, G; Milani, P; Foli, A; Vidus Rosin, M; Basset, M; Lavatelli, F; Nuvolone, M; Obici, L; Perlini, S; Merlini, G (2014). Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: A matched case–control study on 174 patients. Leukemia, 28(12):2311-2316.

Deindl, Philipp; Klar, Martin; Drews, David; Cremer, Malte; Gammella, Elena; Gassmann, Max; Dame, Christof (2014). Mice over-expressing human erythropoietin indicate that erythropoietin enhances expression of its receptor via up-regulated Gata1 and Tal1. Haematologica, 99(10):e205-e207.

Rechsteiner, Markus; Müller, Rouven; Reineke, Tanja; Goede, Jeroen; Bohnert, Annette; Zhong, Qing; Manz, Markus G; Moch, Holger; Wild, Peter J; Zimmermann, Dieter R; Tinguely, Marianne (2014). Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by next generation sequencing. Experimental Hematology & Oncology, 3:18.

Seystahl, K; Weller, M; Bozinov, O; Reimann, R; Rushing, E (2014). Neuropathological characteristics of progression after prolonged response to bevacizumab in multifocal hemangioblastoma. Oncology Research and Treatment, 37(4):209-212.

Beldjord, Kheira; Chevret, Sylvie; Asnafi, Vahid; Huguet, Françoise; Boulland, Marie-Laure; Leguay, Thibaut; Thomas, Xavier; Cayuela, Jean-Michel; Grardel, Nathalie; Chalandon, Yves; Boissel, Nicolas; Schaefer, Beat; Delabesse, Eric; Cavé, Hélène; Chevallier, Patrice; Buzyn, Agnès; Fest, Thierry; Reman, Oumedaly; Vernant, Jean-Paul; Lhéritier, Véronique; Béné, Marie C; Lafage, Marina; Macintyre, Elizabeth; Ifrah, Norbert; Dombret, Hervé (2014). Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood, 123(24):3739-3749.

Palladini, G; Milani, P; Foli, A; Obici, L; Lavatelli, F; Nuvolone, M; Caccialanza, R; Perlini, S; Merlini, G (2014). Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: Long-term results of a risk-adapted approach. Haematologica, 99(4):743-750.

Hitz, Felicitas; Diem, Stefan; Haile, Sarah R; Ess, Silvia; Cerny, Thomas; Mey, Ulrich (2014). Outcome of mantle cell lymphoma patients treated at a single institution over the past decade. Hematological oncology, 32(4):192-196.

Theusinger, Oliver M; Kind, Stephanie L; Seifert, Burkhardt; Borgeat, Lain; Gerber, Christian; Spahn, Donat R (2014). Patient Blood Management in orthopaedic surgery: a four-year follow-up of transfusion requirements and blood loss from 2008 to 2011 at the Balgrist University Hospital in Zurich, Switzerland. Blood Transfusion, 12(2):195-203.

Rechenberg, Dan-K; Bostanci, Nagihan; Zehnder, Matthias; Belibasakis, Georgios N (2014). Periapical fluid RANKL and IL-8 are differentially regulated in pulpitis and apical periodontitis. Cytokine, 69(1):116-119.

Weller, Michael (2014). Primary central nervous system lymphoma in the elderly. Oncology Research and Treatment, 37(7-8):376-377.

Benz, R; Schanz, U; Maggiorini, M; Seebach, J D; Stussi, G (2014). Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transplantation, 49(1):62-65.

Wagner, Claudia C; Held, Ulrike; Kofmehl, Reto; Battegay, Edouard; Zimmerli, Lukas; Hofer, Silvia (2014). Role of arterial hypertension as a predictive marker for bevacizumab efficacy in recurrent glioblastoma - a prospective analysis. Acta Oncologica, 53(4):572-575.

Zhou, T; Georgeon, S; Moser, R; Moore, D J; Caflisch, A; Hantschel, O (2014). Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348). Leukemia, 28(2):404-407.

Riesterer, O; Guckenberger, M (2014). Stereotaktische Strahlentherapie von Metastasen : Palliativer Effekt und Tumorkontrolle. Onkologe, 20(8):757-765.

Aalbers, A M; van den Heuvel-Eibrink, M M; Baumann, I; Beverloo, H B; Driessen, G J; Dworzak, M; Fischer, A; Göhring, G; Hasle, H; Locatelli, F; De Moerloose, B; Noellke, P; Schmugge, M; Stary, J; Yoshimi, A; Zecca, M; Zwaan, C M; van Dongen, J J M; Pieters, R; Niemeyer, C M; van der Velden, V H J; Langerak, A W (2014). T-cell receptor Vβ skewing frequently occurs in refractory cytopenia of childhood and is associated with an expansion of effector cytotoxic T cells: a prospective study by EWOG-MDS. Blood Cancer Journal, 4:e209.

Bandapalli, Obul R; Schuessele, Stephanie; Kunz, Joachim B; Rausch, Tobias; Stütz, Adrian M; Tal, Noa; Geron, Ifat; Gershman, Nava; Izraeli, Shai; Eilers, Juliane; Vaezipour, Nina; Kirschner-Schwabe, Renate; Hof, Jana; von Stackelberg, Arend; Schrappe, Martin; Stanulla, Martin; Zimmermann, Martin; Koehler, Rolf; Avigad, Smadar; Handgretinger, Rupert; Frismantas, Viktoras; Bourquin, Jean Pierre; Bornhauser, Beat; Korbel, Jan O; Muckenthaler, Martina U; Kulozik, Andreas E (2014). The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse. Haematologica, 99(10):e188-e192.

Georgis, Antoin. The combined expression of VPREB3 and ID3 represents a new helpful tool for the routine diagnosis of mature aggressive B-cell lymphomas. 2014, University of Zurich, Faculty of Medicine.

Marek, A; Stern, M; Chalandon, Y; Ansari, M; Ozsahin, H; Güngör, T; Gerber, B; Kühne, T; Passweg, J R; Gratwohl, A; Tichelli, A; Seger, R; Schanz, U; Halter, J; Stussi, G (2014). The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT. Bone Marrow Transplantation, 49(1):55-61.

Streif, W; Knöfler, R; Eberl, W; Andres, O; Bakchoul, T; Bergmann, F; Beutel, K; Dittmer, R; Gehrisch, S; Gottstein, S; Halimeh, S; Haselböck, J; Hassenpflug, W-A; Heine, S; Holzhauer, S; King, S; Kirchmaier, C M; Krause, M; Kreuz, W; Lösche, W; Mahnel, R; Maurer, M; Nimtz-Talaska, A; Olivieri, M; Rott, H; Schambeck, Ch M; Schedel, A; Schilling, F H; Schmugge, M; Schneppenheim, R; Scholz, U; Scholz, T; Schulze, H; Siegemund, A; Strauß, G; Sykora, K-W; Wermes, C; Wiegering, V; Wieland, I; Zieger, B; Zotz, R B (2014). Therapie hereditärer Thrombozytopathien. Interdisziplinäre S2K-Leitlinie der Ständigen Kommission Pädiatrie der Gesellschaft für Thrombose- und Hämostaseforschung e. V. Hämostaseologie, 34(4):269-75, quiz 276.

Voss, M H; Bastos, D A; Karlo, C A; Ajeti, A; Hakimi, A A; Feldman, D R; Hsieh, J J; Molina, A M; Patil, S; Motzer, R J (2014). Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies. Annals of Oncology, 25(3):663-668.

2013

Poretti, Andrea; Meoded, Avner; Cohen, Kenneth J; Grotzer, Michael A; Boltshauser, Eugen; Huisman, Thierry A G M (2013). Apparent diffusion coefficient of pediatric cerebellar tumors: A biomarker of tumor grade? Pediatric Blood & Cancer, 60(12):2036-2041.

Lentz, S R; Misgav, M; Ozelo, M; Salek, S Z; Veljkovic, D; Recht, M; Cerqueira, Manuel; Tiede, A; Brand, B; Mancuso, M E; Seremetis, S; Lindblom, A; Martinowitz, U (2013). Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. Haemophilia, 19(5):691-697.

Schlenk, R F; Taskesen, E; van Norden, Y; Krauter, J; Ganser, A; Bullinger, L; Gaidzik, V I; Paschka, P; Corbacioglu, A; Göhring, G; Kündgen, A; Held, G; Götze, K; Vellenga, E; Kuball, J; Schanz, U; Passweg, J; Pabst, Thomas; Maertens, J; Ossenkoppele, G J; Delwel, R; Döhner, H; Cornelissen, J J; Döhner, K; Löwenberg, B (2013). The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA. Blood, 9(122):1576-1582.

Barthelmes, D; Irhimeh, M R; Gillies, M C; Zhu, L; Shen, W (2013). Isolation and characterization of mouse bone marrow-derived Lin-/VEGF-R2 + progenitor cells. Annals of Hematology, 92(11):1461-1472.

Franke, Kristin; Gassmann, M; Wielockx, B (2013). Erythrocytosis: the HIF pathway in control. Blood, 122(7):1122-1128.

Schaller, M; Studt, J D; Voorberg, J; Kremer Hovinga, J A (2013). Acquired thrombotic thrombocytopenic purpura. Development of an autoimmune response. Hämostaseologie, 33(2):121-130.

Studt, J D; Binet, I; Nair, G; Schanz, U (2013). Heparin-induced thrombocytopenia associated with thrombotic microangiopathy. Hämostaseologie, 2(33):160-163.

Creutzig, Ursula; Zimmermann, Martin; Bourquin, Jean-Pierre; et al (2013). Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004. Blood, 122(1):37-43.

Attarbaschi, Andishe; Beishuizen, Auke; Mann, Georg; Rosolen, Angelo; Mori, Tetsuya; Uyttebroeck, Anne; Niggli, Felix; Csoka, Monika; Krenova, Zdenka; Mellgren, Karin; Kabickova, Edita; Chiang, Alan K S; Reiter, Alfred; Williams, Denise; Burkhardt, Birgit (2013). Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "watch and wait" strategy after complete resection. Annals of Hematology, 92(11):1537-41.

Tiede, A; Brand, B; Fischer, R; Kavakli, K; Lentz, S R; Matsushita, T; Rea, C; Knobe, K; Viuff, D (2013). Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A. Journal of Thrombosis and Haemostasis, 11(4):670-678.

Trück, Johannes; Lazarus, Rajeka; Clutterbuck, Elizabeth A; Bowman, Jaclyn; Kibwana, Elizabeth; Bateman, Elizabeth A L; Pollard, Andrew J (2013). The zwitterionic type I Streptococcus pneumoniae polysaccharide does not induce memory B cell formation in humans. Immunobiology, 218(3):368-72.

von Kanel, T; Röthlisberger, B; Schanz, U; Dutly, F; Huber, A R; Saller, E (2013). A Swiss (εγδβ)(0) -thalassemia patient with a novel 3-Mb deletion associated with mild mental impairment. American Journal of Hematology, 88(2):158-159.

Soldini, D; Montagna, C; Schüffler, P; Martin, V; Georgis, A; Thiesler, T; Curioni-Fontecedro, A; Went, P; Bosshard, G; Dehler, Silvia; Mazzuchelli, L; Tinguely, M (2013). A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome. Annals of Oncology, 24(1):193-201.

Oschlies, Ilske; Lisfeld, Jasmin; Lamant, Laurence; Nakazawa, Atsuko; d'Amore, Emanuele S G; Hansson, Ulrika; Hebeda, Konnie; Simonitsch-Klupp, Ingrid; Maldyk, Jadwiga; Müllauer, Leonhard; Tinguely, Marianne; Stücker, Markus; Ledeley, Marie-Cecile; Siebert, Reiner; Reiter, Alfred; Brugières, Laurence; Klapper, Wolfram; Woessmann, Wilhelm (2013). ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study. Haematologica, 98(1):50-56.

Gerull, S; Stern, M; Ben Aissa, A; Manz, M G; Schanz, U; Stussi, G; Chalandon, Y; Passweg, J; Mohty, B (2013). Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT. Bone Marrow Transplantation, 48(3):408-413.

Mocharla, Pavani; Briand, Sylvie; Giannotti, Giovanna; Dörries, Carola; Jakob, Philipp; Paneni, Francesco; Lüscher, Thomas F; Landmesser, Ulf (2013). AngiomiR-126 expression and secretion from circulating CD34+ and CD14+ PBMCs: role for pro-angiogenic effects and alterations in type-2 diabetics. Blood, 121(1):226-236.

Aalbers, A M; van den Heuvel-Eibrink, M M; de Haas, V; Te Marvelde, J G; de Jong, A X; van der Burg, M; Dworzak, M; Hasle, H; Locatelli, F; De Moerloose, B; Schmugge, M; Stary, J; Zecca, M; Zwaan, C M; van de Loosdrecht, A A; van Dongen, J J M; Niemeyer, C M; van der Velden, V H J (2013). Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood. Leukemia, 27(9):1923-1925.

Vetter, Marcus; Huang, Dorothy Jane; Bosshard, Georg; Güth, Uwe (2013). Breast cancer in women 80 years of age and older: a comprehensive analysis of an underreported entity. Acta Oncologica, 52(1):57-65.

Meixlsperger, Sonja; Leung, Carol S; Rämer, Patrick C; Pack, Maggi; Vanoaica, Liliana D; Breton, Gaëlle; Pascolo, Steve; Salazar, Andres M; Dzionek, Andrzej; Schmitz, Jürgen; Steinman, Ralph M; Münz, Christian (2013). CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice. Blood, 121(25):5034-5044.

Gatta, G; Mallone, S; van der Zwan, J M; Trama, A; Siesling, S; Capocaccia, R (2013). Cancer prevalence estimates in Europe at the beginning of 2000. Annals of Oncology, 24(6):1660-1666.

Lang, Stephanie; Shrestha, Binaya; Graydon, Shaun; Cavelaars, Frederique; Linsenmeier, Claudia; Hrbacek, Jan; Klöck, Stephan; Studer, Gabriela; Riesterer, Oliver (2013). Clinical application of flattening filter free beams for extracranial stereotactic radiotherapy. Radiotherapy and Oncology, 106(2):255-259.

Sigle, J P; Infanti, L; Studt, J D; Martinez, M; Stern, M; Gratwohl, A; Passweg, J; Tichelli, A; Buser, A S (2013). Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components. Transfusion, 53(8):1788-1797.

Perrotta, S; Stiehl, D P; Punzo, F; Scianguetta, S; Borriello, A; Bencivenga, D; Casale, M; Nobili, B; Fasoli, S; Balduzzi, A; Cro, L; Nytko, K J; Wenger, R H; Della Ragione, F (2013). Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. Haematologica:1-34.

Pettengell, Ruth; Silvestre, Antonio Salar; Schwenkglenks, Matthias; Rossi, Francesca Gaia; Duehrsen, Ulrich; Verhoef, Gregor; Lugtenburg, Pieternella Johanna; Wheeler, Tracey; Pujol, Beatriz; Haioun, Corinne (2013). Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R)CHOP. Hematology, 18(1):26-29.

Barthelmes, D; Irhimeh, M R; Gillies, M C; Karimipour, M; Zhou, M; Zhu, L; Shen, W Y (2013). Diabetes impairs mobilization of mouse bone marrow-derived Lin−/VEGF-R2+ progenitor cells. Blood Cells, Molecules & Diseases, 51(3):163-173.

Binz, Patrizia; Bodmer, Nicole; Leibundgut, Kurt; Teuffel, Oliver; Niggli, Felix K; Ammann, Roland A (2013). Different fever definitions and the rate of fever and neutropenia diagnosed in children with cancer: A retrospective two-center cohort study. Pediatric Blood & Cancer, 60(5):799-805.

Sepulveda, Fernando E; Debeurme, Franck; Ménasché, Gaël; Kurowska, Mathieu; Côte, Marjorie; Pachlopnik Schmid, Jana; Fischer, Alain; de Saint Basile, Geneviève (2013). Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11. Blood, 121(4):595-603.

Rueegg, Corina S; Gianinazzi, Micòl E; Michel, Gisela; von der Weid, Nicolas X; Bergstraesser, Eva; Kuehni, Claudia E (2013). Do childhood cancer survivors with physical performance limitations reach healthy activity levels? Pediatric Blood & Cancer, 60(10):1714-1720.

Huber, F L; Latshang, T D; Goede, J S; Bloch, K E (2013). Does venous blood gas analysis provide accurate estimates of hemoglobin oxygen affinity? Annals of Hematology, 92(4):517-521.

Cosgrove, Cormac; Ussher, James E; Rauch, Andri; Gärtner, Kathleen; Kurioka, Ayako; Hühn, Michael H; Adelmann, Krista; Kang, Yu-Hoi; Fergusson, Joannah R; Simmonds, Peter; Goulder, Philip; Hansen, Ted H; Fox, Julie; Günthard, Huldrych F; Khanna, Nina; Powrie, Fiona; Steel, Alan; Gazzard, Brian; Phillips, Rodney E; Frater, John; Uhlig, Holm; Klenerman, Paul (2013). Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood, 121(6):951-961.

Schwenkglenks, Matthias; Bendall, Kate Louise; Pfeil, Alena M; Szabo, Zsolt; Pettengell, Ruth (2013). External validation of a risk model of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma. Leukemia & Lymphoma, 54(11):2426-2432.

Soldini, Davide; Campo, Elias (2013). Genetic sequencing studies in Burkitt's lymphoma: what can we learn about tumorigenesis? Expert Review of Hematology, 6(3):219-21.

Kreth, F W; Thon, N; Simon, M; Westphal, M; Schackert, G; Nikkhah, G; Hentschel, B; Reifenberger, G; Pietsch, T; Weller, M; Tonn, J C (2013). Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy. Annals of Oncology, 24(12):3117-3123.

Franke, Kristin; Kalucka, Joanna; Mamlouk, Soulafa; Singh, Rashim Pal; Muschter, Antje; Weidemann, Alexander; Iyengar, Vasuprada; Jahn, Steffen; Wieczorek, Kathrin; Geiger, Kathrin; Muders, Michael; Sykes, Alex M; Poitz, David; Ripich, Tatsiana; Otto, Teresa; Bergmann, Sybille; Breier, Georg; Baretton, Gustavo; Fong, Guo-Hua; Greaves, David R; Bornstein, Stefan; Chavakis, Triantafyllos; Fandrey, Joachim; Gassmann, Max; Wielockx, Ben (2013). HIF-1α is a protective factor in conditional PHD2 deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis. Blood, 121(8):1436-1445.

Schaer, D J; Buehler, P W; Alayash, A I; Belcher, J D; Vercellotti, G M (2013). Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood, 121(8):1276-1284.

Dörge, Petra; Meissner, Barbara; Zimmermann, Martin; Moericke, Anja; Schrauder, Andre; Bourquin, Jean-Pierre; Schewe, Denis; Harbott, Jochen; Teigler-Schlegel, Andrea; Ratei, Richard; Ludwig, Wolf Dieter; Köhler, Rolf; Bartram, Claus R; Schrappe, Martin; Stanulla, Martin; Cario, Gunnar (2013). IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. Haematologica, 98(3):428-432.

Bonn, Bettina R; Rohde, Marius; Zimmermann, Martin; Krieger, David; Oschlies, Ilske; Niggli, Felix; Wrobel, Grazyna; Attarbaschi, Andishe; Escherich, Gabriele; Klapper, Wolfram; Reiter, Alfred; Burkhardt, Birgit (2013). Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence. Blood, 121(16):3153-3160.

Iolyeva, Maria; Aebischer, David; Proulx, Steven T; Willrodt, Ann-Helen; Ecoiffier, Tatiana; Häner, Simone; Bouchaud, Grégory; Krieg, Carsten; Onder, Lucas; Ludewig, Burkhard; Santambrogio, Laura; Boyman, Onur; Chen, Lu; Finke, Daniela; Halin, Cornelia (2013). Interleukin-7 is produced by afferent lymphatic vessels and supports lymphatic drainage. Blood, 122(13):2271-2281.

Spahn, Donat R; Vamvakas, Eleftherios C (2013). Is best transfusion practice alone best clinical practice? Blood Transfusion, 11(2):172-174.

Mirkowska, Paulina; Hofmann, Andreas; Sedek, Lukasz; Slamova, Lucie; Mejstrikova, Ester; Szczepanski, Tomasz; Schmitz, Maike; Cario, Gunnar; Stanulla, Martin; Schrappe, Martin; van der Velden, Vincent H J; Bornhauser, Beat C; Wollscheid, Bernd; Bourquin, Jean-Pierre (2013). Leukemia surfaceome analysis reveals new disease-associated features. Blood, 121(25):e149-e159.

Nuber, Natko; Curioni-Fontecedro, Alessandra; Dannenmann, Stefanie R; Matter, C; von Boehmer, Lotta; Atanackovic, Djordje; Knuth, Alexander; van den Broek, Maries (2013). MAGE-C1/CT7 spontaneously triggers a CD4+ T-cell response in multiple myeloma patients. Leukemia, 27(8):1767-1769.

Nendaz, M; Spirk, D; Kucher, N; Aujesky, D; Hayoz, D; Beer, J H; Husmann, M; Frauchiger, B; Korte, W; Wuillemin, W A; Jäger, K; Righini, M; Bounameaux, H (2013). Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE). Thrombosis and haemostasis, 111(3):online-.

Koster, M; Amann-Vesti, B R; Husmann, M; Jacomella, V; Meier, T O; Jeanneret, C; Hafner, J; Thalhammer, C (2013). Non-invasive pressure measurement of the great saphenous vein in healthy controls and patients with venous insufficiency. Clinical Hemorheology and Microcirculation, 54(3):325-332.

Ljung, R; Auerswald, G; Benson, G; Jetter, A; Jiménez-Yuste, V; Lambert, T; Morfini, M; Remor, E; Sørensen, B; Salek, S Z (2013). Novel coagulation factor concentrates: issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients. Haemophilia, 19(4):481-486.

Winkler, Jeannine; Rand, Margaret L; Schmugge, Markus; Speer, Oliver (2013). Omi/HtrA2 and XIAP are components of platelet apoptosis signalling. Thrombosis and Haemostasis, 109(3):532-539.

Boi, Michela; Rinaldi, Andrea; Kwee, Ivo; Bonetti, Paola; Piva, Roberto; Rancoita, Paola M V; et al (2013). PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma. Blood, 122(15):2683-2693.

Musallam, Khaled M; Jamali, Faek R; Rosendaal, Frits R; Richards, Toby; Spahn, Donat R; Khavandi, Kaivan; Barakat, Iskandar; Demoss, Benjamin; Lotta, Luca A; Peyvandi, Flora; Sfeir, Pier M (2013). Preoperative hematocrit concentration and the risk of stroke in patients undergoing isolated coronary-artery bypass grafting. Anemia, 2013:206829.

Scherz, Nathalie; Méan, Marie; Limacher, Andreas; Righini, Marc; Jaeger, Kurt; Beer, Hans-Jürg; Frauchiger, Beat; Osterwalder, Joseph; Kucher, Nils; Matter, Christian M; Banyai, Martin; Angelillo-Scherrer, Anne; Lämmle, Bernhard; Husmann, Marc; Egloff, Michael; Aschwanden, Markus; Bounameaux, Henri; Cornuz, Jacques; Rodondi, Nicolas; Aujesky, Drahomir (2013). Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism. Journal of Thrombosis and Haemostasis, 11(3):435-443.

Martin-Guerrero, Idoia; Salaverria, Itziar; Burkhardt, Birgit; Szczepanowski, Monika; Baudis, Michael; Bens, Susanne; de Leval, Laurence; Garcia-Orad, Africa; Horn, Heike; Lisfeld, Jasmin; Pellissery, Shoji; Klapper, Wolfram; Oschlies, Ilske; Siebert, Reiner (2013). Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas. Haematologica, 98(8):1237-1241.

Minetti, Giampaolo; Egée, Stephane; Mörsdorf, Daniel; Steffen, Patrick; Makhro, Asya; Achilli, Cesare; Ciana, Annarita; Wang, Jue; Bouyer, Guillaume; Bernhardt, Ingolf; Wagner, Christian; Thomas, Serge; Bogdanova, Anna; Kaestner, Lars (2013). Red cell investigations: Art and artefacts. Blood Reviews, 27(2):91-101.

Leung, Carol S; Maurer, Michael A; Meixlsperger, Sonja; Lippmann, Anne; Cheong, Cheolho; Zuo, Jianmin; Haigh, Tracey; Taylor, Graham; Münz, Christian (2013). Robust T cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205. Blood, 121(9):1584-1594.

Robach, Paul; Recalcati, Stefania; Girelli, Domenico; Campostrini, Natascia; Kempf, Tibor; Wollert, Kai C; Corbella, Michela; Santambrogio, Paolo; Perbellini, Luigi; Brasse-Lagnel, Carole; Christensen, Britt; Moutereau, Stéphane; Lundby, Carsten; Cairo, Gaetano (2013). Serum hepcidin levels and muscle iron proteins in humans injected with low- or high-dose erythropoietin. European Journal of Haematology, 91(1):74-84.

Morishima, Yasuo; Kawase, Takakazu; Malkki, Mari; Morishima, Satoko; Spellman, Stephen; Kashiwase, Koichi; Kato, Shunichi; Cesbron, Anne; Tiercy, Jean-Marie; Senitzer, David; Velardi, Andrea; Petersdorf, Effie W (2013). Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 19(8):1197-1203.

Pihlgren, Maria; Silva, Alberto B; Madani, Rime; Giriens, Valérie; Waeckerle-Men, Ying; Fettelschoss, Antonia; Hickman, David T; López-Deber, María Pilar; Ndao, Dorin Mlaki; Vukicevic, Marija; Buccarello, Anna Lucia; Gafner, Valérie; Chuard, Nathalie; Reis, Pedro; Piorkowska, Kasia; Pfeifer, Andrea; Kündig, Thomas M; Muhs, Andreas; Johansen, Pål (2013). TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in mice. Blood, 121(1):85-94.

Cippà, Pietro E; Gabriel, Sarah S; Chen, Jin; Bardwell, Philip D; Bushell, Andrew; Guimezanes, Annick; Kraus, Anna K; Wekerle, Thomas; Wüthrich, Rudolf P; Fehr, Thomas (2013). Targeting apoptosis to induce stable mixed hematopoietic chimerism and long-term allograft survival without myelosuppressive conditioning in mice. Blood, 122(9):1669-1677.

Méan, Marie; Righini, Marc; Jaeger, Kurt; Beer, Hans-Jürg; Frauchiger, Beat; Osterwalder, Joseph; Kucher, Nils; Lämmle, Bernhard; Cornuz, Jacques; Angelillo-Scherrer, Anne; Rodondi, Nicolas; Limacher, Andreas; Trelle, Sven; Matter, Christian M; Husmann, Marc; Banyai, Martin; Aschwanden, Markus; Egloff, Michael; Mazzolai, Lucia; Hugli, Olivier; Bounameaux, Henri; Aujesky, Drahomir (2013). The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology. Journal of Thrombosis and Thrombolysis, 36(4):475-483.

Brandt, Simone; Montagna, Chiara; Georgis, Antoin; Schüffler, Peter J; Bühler, Marco M; Seifert, Burkhardt; Thiesler, Thore; Curioni-Fontecedro, Alessandra; Hegyi, Ivan; Dehler, Silvia; Martin, Vittoria; Tinguely, Marianne; Soldini, Davide (2013). The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma. Experimental Hematology & Oncology, 2:27.

2012

Rössle, M; Moch, H (2012). Bedeutung molekularpathologischer Methoden in der Onkologie. Der Onkologe, 18(12):1149-1156.

Dummer, R; Hauschild, A; Guggenheim, M; Keilholz, U; Pentheroudakis, G (2012). Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 23(Sup7):vii86-vii91.

Weder, W (2012). Advances in surgery. Annals of Oncology, 23 Suppl:x43-x45.

Deuel, J W; Lutz, H U; Misselwitz, B; Goede, J S (2012). Asymptomatic elevation of the hyperchromic red blood cell subpopulation is associated with decreased red cell deformability. Annals of Hematology, 91(9):1427-1434.

Hofer, S; Mengele, K; Stemmler, H J; Schmitt, M; Pestalozzi, B (2012). Intrathecal trastuzumab: dose matters. Acta Oncologica, 51(7):955-956.

Lüthi, Fabienne; Leibundgut, Kurt; Niggli, Felix K; Nadal, David; Aebi, Christoph; Bodmer, Nicole; Ammann, Roland A (2012). Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: Results of the prospective multicenter SPOG 2003 FN study. Pediatric Blood & Cancer, 59(1):90-95.

Renner, C; Zinzani, P L; Gressin, R; Klingbiel, D; Dietrich, P Y; Hitz, Felicitas; Bargetzi, M; Mingrone, W; Martinelli, G; Trojan, A; Bouabdallah, K; Lohri, A; Gyan, E; Biaggi, C; Cogliatti, S; Bertoni, F; Ghielmini, M; Brauchli, P; Ketterer, N (2012). A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma. Haematologica, 97(7):1085-1091.

Lauten, Melchior; Möricke, Anja; Beier, Rita; Zimmermann, Martin; Stanulla, Martin; Meissner, Barbara; Odenwald, Edelgard; Attarbaschi, Andishe; Niemeyer, Charlotte; Niggli, Felix; Riehm, Hansjörg; Schrappe, Martin (2012). Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia. Haematologica, 97(7):1048-1056.

Ziegler, P; Schrezenmeier, H; Akkad, J; Brassat, U; Vankann, L; Panse, J; Wilop, S; Balabanov, S; Schwarz, K; Martens, U M; Brümmendorf, T H (2012). Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation. Annals of Hematology, 91(7):1115-1120.

Belloni, B; Johansen, N; Glass, L F; Dummer, R (2012). Recent advances in the management of cutaneous lymphomas. Seminars in Oncology, 39(2):150-162.

Takizawa, H; Boettcher, S; Manz, M G (2012). Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood, 119(13):2991-3002.

Brack, Eva; Bodmer, Nicole; Simon, Arne; Leibundgut, Kurt; Kühne, Thomas; Niggli, Felix K; Ammann, Roland A (2012). First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study. Pediatric Blood & Cancer, 59(3):423-430.

Dummer, R; Beyer, M; Hymes, K; Epping, M T; Bernards, R; Steinhoff, M; Sterry, W; Kerl, H; Heath, K; Ahern, J D; Hardwick, J S; Garcia-Vargas, J; Baumann, K; Rizvi, S; Frankel, S R; Whittaker, S J; Assaf, C (2012). Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition. Leukemia and Lymphoma, 53(8):1501-1508.

Spielmann, N; Mauch, J; Madjdpour, C; Schmugge, M; Weiss, M; Haas, T (2012). Accuracy and precision of hemoglobin point-of-care testing during major pediatric surgery. International journal of laboratory hematology, 34(1):86-90.

Tomčík, Michal; Arima, Kazuhiko; Hulejová, Hana; Kuklová, Markéta; Filková, Mária; Braun, Martin; Beláček, Jaromír; Novák, Marek; Bečvář, Radim; Vencovský, Jiří; Haluzík, Martin; Gay, Steffen; Müller-Ladner, Ulf; Distler, Oliver; Senolt, Ladislav (2012). Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis. Cytokine, 58(2):165-168.

Belibasakis, Georgios N; Johansson, Anders (2012). Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes. Cytokine, 59(1):124-130.

Rebholz, Cornelia E; Kuehni, Claudia E; Strippoli, Marie-Pierre F; Rueegg, Corina S; Michel, Gisela; Hengartner, Heinz; Bergstraesser, Eva; von der Weid, Nicolas X (2012). Alcohol consumption and binge drinking in young adult childhood cancer survivors. Pediatric Blood & Cancer, 58(2):256-264.

Riklin, C; Seystahl, K; Hofer, S; Happold, C; Winterhalder, R; Weller, M (2012). Antiangiogenic treatment for multiple CNS hemangioblastomas. Onkologie, 35(7-8):443-445.

Raju, Uma; Riesterer, Oliver; Wang, Zhi-Qiang; Molkentine, David P; Molkentine, Jessica M; Johnson, Faye M; Glisson, Bonnie; Milas, Luka; Ang, K Kian (2012). Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways. Radiotherapy and Oncology, 105(2):241-249.

Melloul, Emmanuel; Lesurtel, Mickael; Carr, Brian I; Clavien, Pierre-Alain (2012). Developments in liver transplantation for hepatocellular carcinoma. Seminars in Oncology, 39(4):510-521.

Pavlidis, N; Stahel, R; Pentheroudakis, G; Cervantes, A (2012). ESMO Consensus Conferences: another source of ESMO Clinical Practice Guidelines. Annals of Oncology, 23(Supp 7):vii7-vii10.

Creutzig, U; Zimmermann, M; Bourquin, J P; Dworzak, M N; Kremens, B; Lehrnbecher, T; von Neuhoff, C; Sander, A; von Stackelberg, A; Schmid, I; Starý, J; Steinbach, D; Vormoor, J; Reinhardt, D (2012). Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report. Leukemia, 26(4):654-661.

von Moos, R; Seifert, B; Simcock, M; Goldinger, S M; Gillessen, S; Ochsenbein, A; Michielin, O; Cathomas, R; Schläppi, M; Moch, H; Schraml, P H; Mihic-Probst, D; Mamot, C; Schönewolf, N; Dummer, R (2012). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Annals of Oncology, 23(2):531-536.

Dummer, R; Rozati, S; Eggmann, N; Rinderknecht, J; Goldinger, S M (2012). From chemotherapy to targeted treatment. Annals of Oncology, 23(Sup 10):x101-x103.

Jacob, Matthias; Annaheim, Simon; Boutellier, Urs; Hinske, Christian; Rehm, Markus; Breymann, Christian; Krafft, Alexander (2012). Haematocrit is invalid for estimating red cell volume: a prospective study in male volunteers. Blood Transfusion, 10(4):471-479.

Snowden, J A; Saccardi, R; Allez, M; Ardizzone, S; Arnold, R; Cervera, R; Denton, C; Hawkey, C; Labopin, M; Mancardi, G; Martin, R; Moore, J J; Passweg, J; Peters, C; Rabusin, M; Rovira, M; van Laar, J M; Farge, D (2012). Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 47(6):770-790.

Talamo, A; Marazzi, A; Rovo, A; Schanz, U; Tichelli, A; Chalandon, Y; Jotterand, M (2012). High hyperdiploid acute lymphoblastic leukemia in adults shows clonal heterogeneity and chromosomal instability at diagnosis and during the course of the disease. Annals of Hematology, 91(5):793-796.

Romano, Emanuela; Cotari, Jesse W; Barreira da Silva, Rosa; Betts, Brian C; Chung, David J; Avogadri, Francesca; Fink, Mitsu J; St Angelo, Erin T; Mehrara, Babak; Heller, Glenn; Münz, Christian; Altan-Bonnet, Gregoire; Young, James W (2012). Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1. Blood, 119(22):5182-5190.

Bettens, F; Passweg, J; Schanz, U; Chalandon, Y; Heim, D; Güngör, T; Stussi, G; Nicoloso, G; Baldomero, H; Gratwohl, A; Tiercy, J M (2012). Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms. Biology of Blood and Marrow Transplantation, 18(4):608-616.

Zerr, Pawel; Palumbo-Zerr, Katrin; Distler, Alfiya; Tomcik, Michal; Vollath, Stefan; Munoz, Luis E; Beyer, Christian; Dees, Clara; Egberts, Friederike; Tinazzi, Ilaria; Del Galdo, Francesco; Distler, Oliver; Schett, Georg; Spriewald, Bernd M; Distler, Jörg H W (2012). Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease. Blood, 120(14):2909-2917.

Horneber, M; Mehnert, A; Roser, T; Rostock, M (2012). Integrative Aspekte der Thoraxonkologie. Onkologie, 35(Suppl 3):2-5.

Petrausch, Ulf; Tischler, Verena; Weder, Walter; Soltermann, Alex (2012). Is distinct EGFR mutation status proof of second simultaneous primary non-small cell lung cancer? memo - Magazine of European Medical Oncology, 5(2):154-156.

Nehme, Nadine T; Pachlopnik Schmid, Jana; Debeurme, Franck; André-Schmutz, Isabelle; Lim, Annick; Nitschke, Patrick; Rieux-Laucat, Frédéric; Lutz, Patrick; Picard, Capucine; Mahlaoui, Nizar; Fischer, Alain; de Saint Basile, Geneviève (2012). MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood, 119(15):3458-3468.

Haas, Thorsten; Mauch, Jacqueline; Weiss, Markus; Schmugge, Markus (2012). Management of dilutional coagulopathy during pediatric major surgery. Transfusion Medicine and Hemotherapy, 39(2):114-119.

Azzouzi, Imane; Schmugge, Markus; Speer, Oliver (2012). MicroRNAs as components of regulatory networks controlling erythropoiesis. European Journal of Haematology, 89(1):1-9.

Wojakowski, W; Landmesser, U; Bachowski, R; Jadczyk, T; Tendera, M (2012). Mobilization of stem and progenitor cells in cardiovascular diseases. Leukemia, 26(1):23-33.

Zimmermann-Baer, Urs; Capalo, Ralph; Dutly, Fabrizio; Saller, Elisabeth; Troxler, Heinz; Kohler, Malcolm; Frischknecht, Hannes (2012). Neonatal cyanosis due to a new (G)γ-globin variant causing low oxygen affinity: Hb F-Sarajevo [(G)γ102(G4)Asn→Thr, AAC>ACC]. Hemoglobin, 36(2):109-113.

Hofer, S; Marosi, C (2012). News from the Neuro-Oncology front. memo - Magazine of European Medical Oncology, 5(3):169-170.

Winkler, J; Kroiss, S; Rand, M L; Azzouzi, I; Annie Bang, K W; Speer, O; Schmugge, M (2012). Platelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin. British Journal of Haematology, 156(4):508-515.

Ghadjar, P; Simcock, M; Zimmermann, F; Betz, M; Bodis, S; Bernier, J; Studer, G; Aebersold, M (2012). Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94). Radiotherapy and Oncology, 104(2):213-218.

Korfel, A; Weller, M; Martus, P; Roth, P; Klasen, H A; Roeth, A; Rauch, M; Hertenstein, B; Fischer, T; Hundsberger, T; Leithäuser, M; Birnbaum, T; Kirchen, H; Mergenthaler, H G; Schubert, J; Berdel, W; Birkmann, J; Hummel, M; Thiel, E; Fischer, L (2012). Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial. Annals of Oncology, 23(9):2374-2380.

Zwierzina, D; Limacher, A; Méan, M; Righini, M; Jaeger, K; Beer, H-J; Frauchiger, B; Osterwalder, J; Kucher, N; Matter, C M; Banyai, M; Angelillo-Scherrer, A; Lämmle, B; Egloff, M; Aschwanden, M; Mazzolai, L; Hugli, O; Husmann, M; Bounameaux, H; Cornuz, J; Rodondi, N; Aujesky, D (2012). Prospective comparison of clinical prognostic scores in elderly patients with pulmonary embolism. Journal of Thrombosis and Haemostasis, 10(11):2270-2276.

Schuepbach, R A; Madon, J; Ender, M; Galli, P; Riewald, M (2012). Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects. Journal of Thrombosis and Haemostasis, 10(8):1675-1684.

Gerber, Bernhard; Guggenberger, Roman; Fasler, David; Nair, Gayathri; Manz, Markus G; Stussi, Georg; Schanz, Urs (2012). Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole. Blood, 120(12):2390-2394.

Asmis, L M; Alberio, L; Angelillo-Scherrer, A; Korte, W; Mendez, A; Reber, G; Seifert, Burkhardt; Stricker, H; Tsakiris, D A; Wuillemin, W A (2012). Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests A study in 9 Swiss laboratories. Thrombosis Research, 129(4):492-498.

Spahn, Donat R (2012). Severe bleeding in surgical and trauma patients: the role of fibrinogen replacement therapy. Thrombosis Research, 130 Supp:S15-S19.

Berger, M D; Gerber, B; Arn, K; Senn, O; Schanz, U; Stussi, G (2012). Significant reduction of red blood cell transfusion requirements by changing from double- to single-unit transfusion policy in patients receiving intensive chemotherapies or stem cell transplantation. Haematologica, 97(1):116-122.

Klingenberg, Roland; Ketelhuth, Daniel F J; Strodthoff, Daniela; Gregori, Silvia; Hansson, Göran K (2012). Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe⁻/⁻ mice. Immunobiology, 217(5):540-547.

Craig, V J; Tzankov, A; Flori, M; Schmid, C A; Bader, A G; Müller, Anne (2012). Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia, 26(11):2421-2424.

Zhou, Qi; Schneider, Irene C; Edes, Inan; Honegger, Annemarie; Bach, Patricia; Schönfeld, Kurt; Schambach, Axel; Wels, Winfried S; Kneissl, Sabrina; Uckert, Wolfgang; Buchholz, Christian J (2012). T-cell receptor gene transfer exclusively to human CD8+ cells enhances tumor cell killing. Blood, 120(22):4334-4342.

Johnsen, H E; Haioun, C; Lugtenburg, P J; Salar, A; Jaeger, U; Pettengell, R; Rossi, Fg; Verhoef, G; Schwenkglenks, M; Bendall, K; Duehrsen, U (2012). The importance of G-CSF prophylaxis in R-CHOP-14 therapy for diffuse large B-cell lymphoma in routine clinical practice. Leukemia and Lymphoma, 53(5):982-984.

Salar, Antonio; Haioun, Corinne; Rossi, Francesca G; Duehrsen, Ulrich; Pettengell, Ruth; Johnsen, Hans E; Jaeger, Ulrich; Verhoef, Gregor; Schwenkglenks, Matthias; Bacon, Pamela; Bendall, Kate; Lugtenburg, Pieternella J (2012). The need for improved neutropenia risk assessment in DLBCL patients receiving R-CHOP-21: findings from clinical practice. Leukemia Research, 36(5):548-553.

Brodowicz, T; Ciuleanu, T; Crawford, J; Filipits, M; Fischer, J R; Georgoulias, V; Gridelli, C; Hirsch, F R; Jassem, J; Kosmidis, P; Krzakowski, M; Manegold, C; Pujol, J L; Stahel, R; Thatcher, N; Vansteenkiste, J; Minichsdorfer, C; Zöchbauer-Müller, S; Pirker, R; Zielinski, C C (2012). Third CECOG consensus on the systemic treatment of non-small-cell lung cancer. Annals of Oncology, 23(5):1223-1229.

Schlitzer, Andreas; Heiseke, Alexander F; Einwächter, Henrik; Reindl, Wolfgang; Schiemann, Matthias; Manta, Calin-Petru; See, Peter; Niess, Jan-Hendrik; Suter, Tobias; Ginhoux, Florent; Krug, Anne B (2012). Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor. Blood, 119(25):6063-6071.

Fernandes, Juliana F; Rocha, Vanderson; Labopin, Myriam; Neven, Benedicte; Moshous, Despina; Gennery, Andrew R; Friedrich, Wilhelm; Porta, Fulvio; de Heredia, Cristina Diaz; Wall, Donna; Bertrand, Yves; Veys, Paul; Slatter, Mary; Schulz, Ansgar; Chan, Ka Wah; Grimley, Michael; Ayas, Mouhab; Güngör, Tayfun; Ebell, Wolfram; Bonfim, Carmem; Kalwak, Krzysztof; Taupin, Pierre; Blanche, Stéphane; Gaspar, H Bobby; Landais, Paul; Fischer, Alain; Gluckman, Eliane; Cavazzana-Calvo, Marina (2012). Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood? Blood, 119(12):2949-2955.

Breymann, Christian; Krafft, Alexander (2012). Treatment of iron deficiency anemia in pregnancy and postpartum. Transfusion Alternatives in Transfusion Medicine, 12(3-4):135-142.

Horneber, M; Overkamp, F; Rostock, M (2012). Umsetzung integrativer Konzepte - eine Bestandsaufnahme. Onkologie, 35(Suppl 5):3-11.

2011

Barreira da Silva, Rosa; Graf, C; Münz, C (2011). Cytoskeletal stabilization of inhibitory interactions in immunologic synapses of mature human dendritic cells with natural killer cells. Blood, 118(25):6487-6498.

Schmid, M A; Takizawa, H; Baumjohann, D R; Saito, Y; Manz, M G (2011). Bone marrow dendritic cell progenitors sense pathogens via toll-like receptors and subsequently migrate to inflamed lymph nodes. Blood, 118(18):4829-4840.

Zeidler, K; Arn, K; Senn, O; Schanz, U; Stussi, G (2011). Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia. Transfusion, 51(11):2269-2276.

Beeler, P E; Kucher, N; Blaser, J (2011). Sustained impact of electronic alerts on rate of prophylaxis against venous thromboembolism. Thrombosis and Haemostasis, 106(4):734-738.

Vellenga, E; van Putten, W; Ossenkoppele, G J; Verdonck, L F; Theobald, Matthias; Cornelissen, J J; Huijgens, P C; Maertens, J; Gratwohl, A; Schaafsma, R; Schanz, U; Graux, C; Schouten, H C; Ferrant, A; Bargetzi, M; Fey, M F; Löwenberg, B (2011). Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood, 118(23):6037-6042.

Rathinam, C; Poueymirou, W T; Rojas, J; Murphy, A J; Valenzuela, D M; Yancopoulos, G D; Rongvaux, A; Eynon, E E; Manz, M G; Flavell, R A (2011). Efficient differentiation and function of human macrophages in humanized CSF-1 mice. Blood, 118(11):3119-3128.

Jelkmann, W; Lundby, C (2011). Blood doping and its detection. Blood, 118(9):2395-2404.

Schuepbach, R A; Velez, K; Riewald, M (2011). Activated protein C up-regulates procoagulant tissue factor activity on endothelial cells by shedding the TFPI Kunitz 1 domain. Blood, 117(23):6338-6346.

Arn, K D; Dazzi, H; Went, P; Goede, J S; Stussi, G (2011). Erythroleukaemia at second glance. European Journal of Haematology, 86(4):358-359.

Guizouarn, H; Borgese, F; Gabillat, N; Harrison, P; Goede, J S; McMahon, C; Stewart, G W; Bruce, L J (2011). South-east Asian ovalocytosis and the cryohydrocytosis form of hereditary stomatocytosis show virtually indistinguishable cation permeability defects. British Journal of Haematology, 152(5):655-664.

Krieg, A H; Hefti, F; Speth, B M; Jundt, G; Guillou, L; Exner, U G; von Hochstetter, A R; Cserhati, M D; Fuchs, B; Mouhsine, E; Kaelin, A; Klenke, F M; Siebenrock, K A (2011). Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors. Annals of Oncology, 22(2):458-467.

Zhang, W; Winder, T; Ning, Y; Pohl, A; Yang, D; Kahn, M; Lurje, G; LaBonte, M J; Wilson, P M; Gordon, M A; Hu-Lieskovan, S; Mauro, D J; Langer, C; Rowinsky, E K; Lenz, H-J (2011). A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. Annals of Oncology, 22(1):104-109.

Rochlitz, C; Ruhstaller, T; Lerch, S; Spirig, C; Huober, J; Suter, T; Buhlmann, M; Fehr, M; Schönenberger, A; von Moos, R; Winterhalder, R; Rauch, D; Muller, A; Mannhart-Harms, M; Herrmann, R; Cliffe, B; Mayer, M; Zaman, K (2011). Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06). Annals of Oncology, 22(1):80-85.

Mueller, R J; Stüssi, G; Puga Yung, G; Nikolic, M; Soldini, D; Halter, J; Meyer-Monard, S; Gratwohl, A; Passweg, J R; Odermatt, B; Schanz, U; Biedermann, B C; Seebach, J D (2011). Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation. Haematologica, 96(1):119-127.

Stahel, R; Thatcher, N; Früh, M; Le Péchoux, C; Postmus, P E; Sorensen, J B; Felip, E (2011). 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer. Annals of Oncology, 22(9):1973-1980.

Rizzi, M; Zurbriggen, K; Schmid, M; Goede, J S; Nardi, M A; Schmugge, M; Speer, O (2011). A new α1-globin mutation, Hb Brugg [α20(B1)His→Gln]. Hemoglobin, 35(4):417-422.

Olk-Batz, C; Poetsch, A R; Nöllke, P; Claus, R; Zucknick, M; Sandrock, I; Witte, T; Strahm, B; Hasle, H; Zecca, M; Stary, J; Bergstraesser, E; De Moerloose, B; Trebo, M; van den Heuvel-Eibrink, M M; Wojcik, D; Locatelli, F; Plass, C; Niemeyer, C M; Flotho, C (2011). Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood, 117(18):4871-4880.

Wlodarski, M W; Mötter, J; Gorr, T A; Olk-Batz, C; Hasle, H; Dworzak, M; Niemeyer, C M; Flotho, C (2011). Abnormal promoter DNA methylation in juvenile myelomonocytic leukemia is not caused by mutation in DNMT3A. Blood, 118(16):4490-4491.

Reinhart, W H; Geissmann-Ott, C; Bogdanova, A (2011). Activation of N-methyl D-aspartate (NMDA) receptors has no influence on rheological properties of erythrocytes. Clinical Hemorheology and Microcirculation, 49(1-4):307-313.

Joerger, M; Matter-Walstra, K; Früh, M; Kühnel, U; Szucs, T; Pestalozzi, B; Schwenkglenks, M (2011). Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis. Annals of Oncology, 22(3):567-574.

Seger, R A (2011). Advances in the diagnosis and treatment of chronic granulomatous disease. Current Opinion in Hematology, 18(1):36-41.

Isbister, J P; Shander, A; Spahn, D R; Erhard, J; Farmer, S L; Hofmann, A (2011). Adverse blood transfusion outcomes: establishing causation. Transfusion Medicine Reviews, 25(2):89-101.

Schmitz, M; Bourquin, J P; Bornhauser, B C (2011). Alternative technique for intrafemoral injection and bone marrow sampling in mouse transplant models. Leukemia and Lymphoma, 52(9):1806-1808.

Thelwel, C; Rigsby, P; Longstaff, C (2011). An international collaborative study to establish the WHO 1st international standards for C1-inhibitor, plasma and concentrate. Journal of Thrombosis and Haemostasis, 9(10):2097-2099.

Haioun, C; Salar, A; Pettengell, R; Johnsen, H E; Duehrsen, U; Rossi, F G; Verhoef, G; Schwenkglenks, M; Jaeger, U; Hamilton, L; Pujol, B; Lugtenburg, P J (2011). Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study. Leukemia and Lymphoma, 52(5):796-803.

Shander, A; Fink, A; Javidroozi, M; Erhard, J; Farmer, S L; Corwin, H; Goodnough, L T; Hofmann, A; Isbister, J; Ozawa, S; Spahn, D R (2011). Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes. Transfusion Medicine Reviews, 25(3):232-246.e53.

Kozlowski, E; Pavão, M S G; Borsig, L (2011). Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin. Journal of Thrombosis and Haemostasis, 9(9):1807-1815.

Creutzig, U; Zimmermann, M; Bourquin, J P; Dworzak, M N; Fleischhack, G; von Neuhoff, C; Sander, A; Schrauder, A; von Stackelberg, A; Ritter, J; Starý, J; Reinhardt, D (2011). CNS irradiation in pediatric acute myleoid leukemia: equal results by 12 or 18 Gy in studies AML-BFM98 and 2004. Pediatric Blood & Cancer, 57(6):986-992.

Spirk, D; Aujesky, D; Husmann, M; Hayoz, D; Baldi, T; Frauchiger, B; Banyai, M; Baumgartner, I; Kucher, N (2011). Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index. The SWIss Venous ThromboEmbolism Registry (SWIVTER). Thrombosis and Haemostasis, 106(5):978-984.

Hofer, S; Elandt, K; Greil, R; Hottinger, A F; Huber, U; Lemke, D; Marosi, C; Ochsenbein, A; Pichler, J; Roelcke, U; Weder, P; Zander, T; Wick, W; Weller, M (2011). Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials. Acta Oncologica, 50(5):630-635.

Pachlopnik Schmid, Jana; Canioni, D; Moshous, D; et al (2011). Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood, 117(5):1522-1529.

György, B; Módos, K; Pállinger, E; Pálóczi, K; Pásztói, M; Misják, P; Deli, M A; Sipos, A; Szalai, A; Voszka, I; Polgár, A; Tóth, K; Csete, M; Nagy, G; Gay, S; Falus, A; Kittel, A; Buzás, E I (2011). Detection and isolation of cell-derived microparticles are compromised by protein complexes due to shared biophysical parameters. Blood, 117(4):e39.

Teuffel, O; Kuster, S P; Hunger, S P; Conter, V; Hitzler, J; Ethier, M C; Shah, P S; Beyene, J; Sung, L (2011). Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia, 25(8):1232-1238.

Kempf, W; Pfaltz, K; Vermeer, M H; Cozzio, A; Ortiz-Romero, P L; Bagot, M; Olsen, E; Kim, Y H; Dummer, R; Pimpinelli, N; Whittaker, S; Hodak, E; Cerroni, L; Berti, E; Horwitz, S; Prince, H M; Guitart, J; Estrach, T; Sanches, J A; Duvic, M; Ranki, A; Dreno, B; Ostheeren-Michaelis, S; Knobler, R; Wood, G; Willemze, R (2011). EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood, 118(15):218-225.

Lohse, I; Lang, S; Hrbacek, J; Scheidegger, S; Bodis, S; Macedo, N; Feng, J; Lütolf, U M; Zaugg, K (2011). Effect of high dose per pulse flattening filter-free beams on cancer cell survival. Radiotherapy and Oncology, 101(1):226-232.

Knols, R H; de Bruin, E D; Uebelhart, D; Aufdemkampe, G; Schanz, U; Stenner-Liewen, F; Hitz, F; Taverna, C; Aaronson, N K (2011). Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial. Bone Marrow Transplantation, 46(9):1245-1255.

Bostanci, N; Akgül, B; Tsakanika, V; Allaker, R P; Hughes, F J; McKay, I J (2011). Effects of low-dose doxycycline on cytokine secretion in human monocytes stimulated with Aggregatibacter actinomycetemcomitans. Cytokine, 56(3):656-661.

De Franceschi, L; Tomelleri, C; Matte, A; Brunati, A M; Bovee-Geurts, P H; Bertoldi, M; Lansoder, E; Tibaldi, E; Danek, A; Walker, R H; Jung, H H; Bader, B; Siciliano, A; Ferru, E; Mohandas, N; Bosman, G J (2011). Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity. Blood, 118(20):5652-5663.

Karpova, M B; Fujii, K; Jenni, D; Dummer, R; Urosevic-Maiwald, M (2011). Evaluation of lymphangiogenic markers in Sézary syndrome. Leukemia and Lymphoma, 52(3):491-501.

Pavlidis, N; Stahel, R; Hansen, H; Cervantes, A (2011). Fourteen years of evolution of ESMO Guidelines: from the minimum recommendations to the Consensus Conference-derived guidelines. Annals of Oncology, 22(Suppl 6):vi7-vi11.

Strahm, B; Nöllke, P; Zecca, M; Korthof, E T; Bierings, M; Furlan, I; Sedlacek, P; Chybicka, A; Schmugge, M; Bordon, V; Peters, C; O'Marcaigh, A; de Heredia, C D; Bergstraesser, E; Moerloose, B D; van den Heuvel-Eibrink, M M; Starý, J; Trebo, M; Wojcik, D; Niemeyer, C M; Locatelli, F (2011). Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia, 25(3):455-462.

Kiessling, M K; Oberholzer, P A; Mondal, C; Karpova, M B; Zipser, M C; Lin, W M; Girardi, M; MacConaill, L E; Kehoe, S M; Hatton, C; French, L E; Garraway, L A; Polier, G; Süss, D; Klemke, C D; Krammer, P H; Gülow, K; Dummer, R (2011). High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade. Blood, 117(8):2433-2440.

Valsami, S; Ruf, W; Leikauf, M S; Madon, J; Kaech, A; Asmis, L M (2011). Immunomodulatory drugs increase endothelial tissue factor expression in vitro. Thrombosis Research, 127(3):264-271.

Brotschi, B; Hug, M I; Latal, B; Neuhaus, D; Buerki, C; Kroiss, S; Spoerri, C; Albisetti, M (2011). Incidence and predictors of indwelling arterial catheter-related thrombosis in children. Journal of Thrombosis and Haemostasis, 9(6):1157-1162.

Pettengell, R; Schwenkglenks, M (2011). Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups. Leukemia and Lymphoma, 52(6):1133-1136.

Spirk, D; Husmann, M; Willenberg, T; Banyai, M; Frank, U; Baldi, T; Amann-Vesti, B; Baumgartner, I; Kucher, N (2011). Inconsistencies in the planning of the duration of anticoagulation among outpatients with acute deep-vein thrombosis. Results from the OTIS-DVT registry. Thrombosis and Haemostasis, 105(2):239-244.

Kovari, H; Weber, R (2011). Influence of antiretroviral therapy on liver disease. Current Opinion in HIV and AIDS, 6(4):272-277.

Mauch, J; Spielmann, N; Hartnack, Sonja; Madjdpour, C; Kutter, Annette P N; Bettschart-Wolfensberger, Regula; Weiss, M; Haas, T (2011). Intrarater and interrater variability of point of care coagulation testing using the ROTEM delta. Blood Coagulation and Fibrinolysis, 22(8):662-666.

Butsch, R; Waelti, S L; Schaerer, S; Braun, J; Korol, D; Probst-Hensch, N; Moch, H; Kurrer, M (2011). Intratumoral plasmacytoid dendritic cells associate with increased survival in patients with follicular lymphoma. Leukemia and Lymphoma, 52(7):1230-1238.

Krayenbuehl, P A; Battegay, E; Breymann, C; Furrer, J; Schulthess, G (2011). Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood, 118(12):3222-3227.

Schrappe, M; Valsecchi, M G; Bartram, C R; Schrauder, A; Panzer-Grümayer, R; Möricke, A; Parasole, R; Zimmermann, M; Dworzak, M; Buldini, B; Reiter, A; Basso, G; Klingebiel, T; Messina, C; Ratei, R; Cazzaniga, G; Koehler, R; Locatelli, F; Schäfer, B W; Aricò, M; Welte, K; van Dongen, J J M; Gadner, H; Biondi, A; Conter, V (2011). Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood, 118(8):2077-2084.

Rovó, A; Daikeler, T; Halter, J; Heim, D; Tsakiris, D A; Stern, M; Waltimo, T; Studt, J D; Tyndall, A; Gratwohl, A; Tichelli, A (2011). Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor. Haematologica, 96(1):150-155.

Spirk, D; Ugi, J; Korte, W; Husmann, M; Hayoz, D; Baldi, T; Frauchiger, B; Banyai, M; Aujesky, D; Baumgartner, I; Kucher, N (2011). Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer. The SWIss Venous ThromboEmbolism Registry (SWIVTER) II. Thrombosis and Haemostasis, 105(6):962-967.

Ayers, L; Kohler, M; Harrison, P; Sargent, I; Dragovic, R; Schaap, M; Nieuwland, R; Brooks, S A; Ferry, B (2011). Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay. Thrombosis Research, 127(4):370-377.

Broggini-Tenzer, A; Vuong, V; Pruschy, M (2011). Metabolism of tumors under treatment: mapping of metabolites with quantitative bioluminescence. Radiotherapy and Oncology, 99(3):398-403.

Felip, E; Gridelli, C; Baas, P; Rosell, R; Stahel, R (2011). Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010. Annals of Oncology, 22(7):1507-1519.

Craig, V J; Cogliatti, S B; Imig, J; Renner, C; Neuenschwander, S; Rehrauer, H; Schlapbach, R; Dirnhofer, S; Tzankov, A; Müller, Anne (2011). Myc-mediated repression of microRNA-34a promotes high grade transformation of B-cell lymphoma by dysregulation of FoxP1. Blood, 117(23):6227-6236.

Burkhardt, B; Oschlies, I; Klapper, W; Zimmermann, M; Woessmann, W; Meinhardt, A; Landmann, E; Attarbaschi, A; Niggli, F; Schrappe, M; Reiter, A (2011). Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols. Leukemia, 25(1):153-160.

Spirk, D; Banyai, M; Jacomella, V; Frank, U; Baldi, T; Baumgartner, I; Amann-Vesti, B; Kucher, N; Husmann, M (2011). Outpatient management of acute deep vein thrombosis: Results from the OTIS-DVT registry. Thrombosis Research, 127(5):406-410.

Pettengell, R; Schwenkglenks, M; Bacon, P; Lawrinson, S; Duehrsen, U (2011). Pegfilgrastim primary prophylaxis in patients with non-Hodgkin lymphoma: results from an integrated analysis. Hematological Oncology, 29(4):177-184.

Samaras, P; Blickenstorfer, M; Siciliano, R D; Haile, S R; Buset, E M; Petrausch, U; Mischo, A; Honegger, H; Schanz, U; Stüssi, G; Stahel, R A; Knuth, A; Stenner-Liewen, F; Renner, C (2011). Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim. Annals of Hematology, 90(1):89-94.

Ess, S; Joerger, M; Frick, H; Probst-Hensch, N; Vlastos, G; Rageth, C; Lütolf, U; Savidan, A; Thürlimann, B (2011). Predictors of state-of-the-art management of early breast cancer in Switzerland. Annals of Oncology, 22(3):618-624.

Levi, M; Fries, D; Gombotz, H; van der Linden, P; Nascimento, B; Callum, J L; Bélisle, S; Rizoli, S; Hardy, J-F; Johansson, P I; Samama, C M; Grottke, O; Rossaint, R; Henny, C P; Goslings, J C; Theusinger, O M; Spahn, D R; Ganter, M T; Hess, J R; Dutton, R P; Scalea, T M; Levy, J H; Spinella, P C; Panzer, S; Reesink, H W (2011). Prevention and treatment of coagulopathy in patients receiving massive transfusions. Vox Sanguinis, 101(2):154-174.

Porter, J B; Lin, K H; Beris, P; Forni, G L; Taher, A; Habr, D; Domokos, G; Roubert, B; Thein, S L (2011). Response of iron overload to deferasirox in rare transfusion-dependent anaemias: equivalent effects on serum ferritin and labile plasma iron for haemolytic or production anaemias. European Journal of Haematology, 87(4):338-348.

Díaz, V; Lombardi, G; Ricci, C; Jacobs, R A; Montalvo, Z; Lundby, C; Banfi, G (2011). Reticulocyte and haemoglobin profiles in elite triathletes over four consecutive seasons. International Journal of Laboratory Hematology, 33(6):638-644.

Creutzig, U; Zimmermann, M; Bourquin, J P; Dworzak, M N; von Neuhoff, C; Sander, A; Schrauder, A; Teigler-Schlegel, A; Stary, J; Corbacioglu, S; Reinhardt, D (2011). Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16). Blood, 118(20):5409-5415.

Daikeler, T; Labopin, M; Di Gioia, M; et al; Güngör, Tayfun (2011). Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party. Blood, 118(6):1693-1698.

Belibasakis, G N; Meier, A; Guggenheim, B; Bostanci, N (2011). The RANKL-OPG system is differentially regulated by supragingival and subgingival biofilm supernatants. Cytokine, 55(1):98-103.

Bermudez-Fajardo, A; Stark, A-K; Penichet, M L; Hölzle, K; Wittenbrink, M M; Hölzle, L; Oviedo-Orta, E (2011). The effect of Chlamydophila pneumoniae Major Outer Membrane Protein (MOMP) on macrophage and T cell-mediated immune responses. Immunobiology, 216(1-2):152-163.

Andreou, D; Bielack, S S; Carrle, D; Kevric, M; Kotz, R; Winkelmann, W; Jundt, G; Werner, M; Fehlberg, S; Kager, L; Kühne, T; Lang, S; Dominkus, M; Exner, G U; Hardes, J; Hillmann, A; Ewerbeck, V; Heise, U; Reichardt, P; Tunn, P-U (2011). The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Annals of Oncology, 22(5):1228-1235.

Senolt, L; Kryštůfková, O; Hulejová, H; Kuklová, M; Filková, M; Cerezo, L A; Běláček, J; Haluzík, M; Forejtová, S; Gay, S; Pavelka, K; Vencovsky, J (2011). The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy. Cytokine, 55(1):116-121.

Abdalla, S; Fu, X; Elzahwy, S S; Klaetschke, K; Streichert, T; Quitterer, U (2011). Up-regulation of the cardiac lipid metabolism at the onset of heart failure. Cardiovascular & hematological agents in medicinal chemistry, 9(3):190-206.

Nytko, K J; Nobuyo, M; Schlaefli, P; Spielmann, P; Wenger, R H; Stiehl, D P (2011). Vitamin C is dispensable for oxygen sensing in vivo. Blood, 117(20):5485-5493.

Booth, C; Gilmour, K C; Veys, P; et al; Pachlopnik Schmid, Jana (2011). X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood, 117(1):53-62.

Schmitz, M; Breithaupt, P; Scheidegger, N; Cario, G; Bonapace, L; Meissner, B; Mirkowska, P; Tchinda, J; Niggli, F K; Stanulla, M; Schrappe, M; Schrauder, A; Bornhauser, B C; Bourquin, J P (2011). Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment. Blood, 118(7):1854-1864.

2010

Hess, V; Pratsch, S; Potthast, S; Lee, L; Winterhalder, R; Widmer, L; Cescato, C; Lohri, A; Jost, L; Stillhart, P; Pestalozzi, B; Herrmann, R (2010). Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial. Annals of Oncology, 21(12):2390-2395.

Craig, V J; Arnold, I; Gerke, C; Huynh, M Q; Wundisch, T; Neubauer, A; Renner, C; Falkow, S; Müller, Anne (2010). Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood, 115(3):581-591.

Weder, W (2010). Mesothelioma. Annals of Oncology, 21 Sup:vii326-vii333.

Setlur, S R; Ihm, C; Tchinda, J; Shams, S; Werner, L; Cho, E K; Thompson, C; Phillips, K; Rassenti, L Z; Kipps, T J; Neuberg, D; Freedman, A S; Lee, C; Brown, J R (2010). Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization. British Journal of Haematology, 151(4):336-345.

Petrausch, U; Samaras, P; Haile, S R; Veit-Haibach, P; Soyka, J D; Knuth, A; Hany, T F; Mischo, A; Renner, C; Schäefer, N G (2010). Risk adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first line therapy. Annals of Oncology, 21(8):1694-1698.

Fantin, Alessandro; Vieira, Joaquim M; Gestri, Gaia; Denti, Laura; Schwarz, Quenten; Prykhozhij, Sergey; Peri, Francesca; Wilson, Stephen W; Ruhrberg, Christiana (2010). Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood, 116(5):829-840.

Bourquin, J P; Bornhauser, B (2010). Have chemosensitizing strategies for multidrug-resistant childhood acute lymphoblastic leukemia come of age? Expert Review of Hematology, 3(4):369-372.

Theusinger, O M; Baulig, W; Asmis, L M; Seifert, B; Spahn, D R (2010). In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM®). Thrombosis and Haemostasis, 104(2):385-391.

Al-Idrissi, E; ElGhazali, G; Alzahrani, M; Ménasché, Gaël; Pachlopnik Schmid, Jana; Geneviève de Saint, Basile (2010). Premature birth, respiratory distress, intracerebral hemorrhage, and silvery-gray hair: differential diagnosis of the 3 types of Griscelli syndrome. Journal of Pediatric Hematology/Oncology, 32(6):494-496.

Sostak, P; Padovan, C S; Eigenbrod, S; Roeber, S; Segerer, S; Schankin, C; Siegert, S; Saam, T; Theil, D; Kolb, H J; Kretzschmar, H; Straube, A (2010). Cerebral angiitis in four patients with chronic GVHD. Bone Marrow Transplantation, 45(7):1181-1188.

Pavlidis, N; Hansen, H; Stahel, R (2010). ESMO Clinical Practice Guidelines: development, implementation and dissemination. Annals of Oncology, 21(Suppl):v7-v8.

Skvortsova, I; Skvortsov, S; Raju, U; Stasyk, T; Riesterer, O; Schottdorf, E-M; Popper, B-A; Schiestl, B; Eichberger, P; Debbage, P; Neher, A; Bonn, G K; Huber, L A; Milas, L; Lukas, P (2010). Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse. Radiotherapy and Oncology, 96(1):108-115.

Stahel, R A; Weder, W; Lievens, Y; Felip, E (2010). Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 21(Suppl):v126-v128.

Thalhammer, C; Ferriani, V; Husmann, M; Rufibach, K; Meier, T; Amann-Vesti, B R (2010). Predictive value of duplex ultrasound for restenosis after renal artery stenting. Clinical Hemorheology and Microcirculation, 45(2-4):217-224.

Lifshitz, L; Tabak, G; Mittelman, M; Gassmann, M; Neumann, D (2010). Macrophages as novel targets for erythropoietin. Haematologica, 95(11):1823-1831.

Stussi, G; Halter, J; Tichelli, A; Meyer-Monard, S; Arber, C; Heim, D (2010). Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies. Bone Marrow Transplantation, 45(1):103-109.

Rovo, A; Stussi, G; Meyer-Monard, S; Favre, G; Tsakiris, D; Heim, D; Halter, J; Arber, C; Passweg, J; Gratwohl, A; Tichelli, A (2010). Sideroblastic changes of the bone marrow can be predicted by the erythrogram of peripheral blood. International Journal of Laboratory Hematology, 32(3):329-335.

Misselwitz, B; Goede, J S; Pestalozzi, B C; Schanz, U; Seebach, J D (2010). Hyperlipidemic myeloma: review of 53 cases. Annals of Hematology, 89(6):569-577.

Rettig, Lorna; Haen, Sebastian P; Bittermann, Anne Greet; von Boehmer, Lotta; Curioni, Alessandra; Krämer, Stefanie D; Knuth, Alexander; Pascolo, Steve (2010). Particle size and activation threshold: a new dimension of danger signaling. Blood, 115(22):4533-4541.

Aapro, M; Schwenkglenks, M; Lyman, G H; Lopez Pousa, A; Lawrinson, S; Skacel, T; Bacon, P; von Minckwitz, G (2010). Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy. Critical Reviews in Oncology / Hematology, 74(3):203-210.

Ortner, E; Schroeder, V; Walser, R; Zerbe, O; Kohler, H-P (2010). Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events. Blood, 115(24):5089-5096.

Petrausch, U; Samaras, P; Veit-Haibach, P; Tschopp, A; Soyka, J D; Knuth, A; Hany, T F; Mischo, A; Renner, C; Schaefer, N G (2010). Hodgkin's lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up? Annals of Oncology, 21(5):1053-1057.

Kucher, N; Spirk, D; Baumgartner, I; Mazzolai, L; Korte, W; Nobel, D; Banyai, M; Bounameaux, H (2010). Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER). Annals of Oncology, 21(5):931-935.

Crinò, L; Weder, W; van Meerbeeck, J; Felip, E (2010). Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 21(S 5):v103-v115.

Lanz, Tobias V; Opitz, Christiane A; Ho, Peggy P; Agrawal, Ankur; Lutz, Christian; Weller, Michael; Mellor, Andrew L; Steinman, Lawrence; Wick, Wolfgang; Platten, Michael (2010). Mouse mesenchymal stem cells suppress antigen-specific TH-cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1). Stem Cells and Development, 19(5):657-668.

Borsig, L (2010). Antimetastatic activities of heparins and modified heparins. Experimental evidence. Thrombosis Research, 125(Suppl2):S66-S71.

Samaras, P; Heider, H; Haile, S R; Petrausch, U; Schaefer, N G; Siciliano, R D; Meisel, A; Mischo, Axel; Zweifel, M; Knuth, A; Stenner-Liewen, F; Renner, Christoph (2010). Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP. Annals of Hematology, 89(8):783-787.

Jungraithmayr, W; Inci, I; Bain, M; Hillinger, S; Korom, S; Weder, W (2010). Distribution of macrophages and T cells in syngrafts and allografts after experimental rat lung transplantation. Immunobiology, 215(3):206-214.

Batz, C; Hasle, H; Bergsträsser, E; van den Heuvel-Eibrink, M M; Zecca, M; Niemeyer, C M; Flotho, C (2010). Does SPRED1 contribute to leukemogenesis in juvenile myelomonocytic leukemia (JMML)? Blood, 115(12):2557-25578.

Moch, H (2010). Neue Aspekte der Pathologie des Nierenzellkarzinoms. Der Onkologe, 16(2):131-139.

Breitenstein, Alexander; Kühne, R; Minder, E I; Marek, A; Goede, J; Schanz, U; Renner, C (2010). Abdominal pain in a patient with acute lymphoblastic leukaemia. Annals of Hematology, 89(2):211-212.

Schuepbach, R A; Riewald, M (2010). Coagulation factor Xa cleaves protease-activated receptor-1 and mediates signaling dependent on binding to the endothelial protein C receptor. Journal of Thrombosis and Haemostasis, 8(2):379-388.

Stiefel, F; Barth, J; Bensing, J; Fallowfield, L; Jost, L; Razavi, D; Kiss, A (2010). Communication skills training in oncology: a position paper based on a consensus meeting among European experts in 2009. Annals of Oncology, 21(2):204-207.

Benz, R; Stüssi, G; Fehr, J (2010). Interferon as an alternative to purine analogues in the treatment of hairy cell leukaemia. British Journal of Haematology, 148(4):664-666.

Power, D G; Feilchenfeldt, J (2010). Irinotecan and mismatch repair deficiency. Annals of Oncology, 21(2):432-433.

Parolini, O; Alviano, F; Bergwerf, I; Boraschi, D; De Bari, C; De Waele, P; Dominici, M; Evangelista, M; Falk, W; Hennerbichler, S; Hess, D C; Lanzoni, G; Liu, B; Marongiu, F; McGuckin, Colin; Mohr, S; Nolli, M L; Ofir, R; Ponsaerts, P; Romagnoli, L; Solomon, A; Soncini, M; Strom, S; Surbek, D; Venkatachalam, S; Wolbank, S; Zeisberger, Steffen; Zeitlin, A; Zisch, A; Borlongan, C V (2010). Toward cell therapy using placenta-derived cells: Disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells and Development, 19(2):143-154.

Creutzig, U; Zimmermann, M; Dworzak, M; Urban, C; Henze, G; Kremens, B; Lakomek, M; Bourquin, J P; Stary, J; Reinhardt, D (2010). Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses. British Journal of Haematology, 149(3):399-409.

Meek, B; Cloosen, S; Borsotti, C; Van Elssen, C H; Vanderlocht, J; Schnijderberg, M C; van der Poel, M W; Leewis, B; Hesselink, R; Manz, M G; Katsura, Y; Kawamoto, H; Germeraad, W T; Bos, G M (2010). In vitro-differentiated T/natural killer-cell progenitors derived from human CD34+ cells mature in the thymus. Blood, 115(2):261-265.

Adam, M; von der Weid, N; Michel, G; Zwahlen, M; Lutz, J M; Probst-Hensch, N; Niggli, F; Kuehni, C (2010). Access to specialized pediatric cancer care in Switzerland. Pediatric Blood & Cancer, 54(5):721-727.

Shander, A; Hofmann, A; Ozawa, S; Theusinger, O M; Gombotz, H; Spahn, D R (2010). Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion, 50(4):753-765.

Craig, V J; Cogliatti, S B; Arnold, I; Gerke, C; Balandat, J-E; Wündisch, T; Müller, Anne (2010). B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis. Leukemia, (24):1186-1196.

Guethlin, C; Walach, H; Naumann, J; Bartsch, H H; Rostock, M (2010). Characteristics of cancer patients using homeopathy compared with those in conventional care: a cross-sectional study. Annals of Oncology, 21(5):1094-1099.

Frischknecht, H; Troxler, H; Dutly, F; Walker, L C; Hohenadel, B A; Eng, B; Waye, J S (2010). Characterization of three novel delta chain hemoglobin variants and two delta-thalassemia alleles. Hemoglobin, 34(4):374-382.

Bordon, V; Gennery, A R; Slatter, M A; Vandecruys, E; Laureys, G; Veys, P; Friedrich, W; Qasim, W; Wulfraat, N M; Scherer, F; Cant, A J; Fischer, A; Cavazanna-Calvo, M; Bredius, R G M; Notarangelo, L D; Mazzolari, E; Neven, B; Güngör, Tayfun (2010). Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation. Blood, 116(1):27-35.

Göhring, G; Michalova, K; et al; Betts, D (2010). Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood, 116(19):3766-3769.

Bogdanova, A; Goede, J S; Weiss, E; Bogdanov, N; Benneku, P; Bernhardt, I; Lutz, H U (2010). Cryohydrocytosis: increased activity of cation carriers in red cells from a patient with a band 3 mutation. Haematologica, 95(2):189-198.

Hertzberg, L; Vendramini, E; Ganmore, I; Cazzaniga, G; Schmitz, M; Chalker, J; Shiloh, R; Iacobucci, I; Shochat, C; Zeligson, S; Cario, G; Stanulla, M; Strehl, S; Russell, L J; Harrison, C J; Bornhauser, B; Yoda, A; Rechavi, G; Bercovich, D; Borkhardt, A; Kempski, H; te Kronnie, G; Bourquin, J P; Domany, E; Izraeli, S (2010). Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood, 115(5):1006-1017.

Soltermann, A; Opitz, I; Tischler, V; Thies, S; Morra, L; Stahel, R A; Weder, W; Moch, H (2010). EMT in NSCLC and malignant pleural mesothelioma. memo - Magazine of European Medical Oncology, 3(4):180-184.

Gerber, B; Nair, G; Stüssi, G (2010). Erythroblastic islands. British Journal of Haematology, 150(5):499.

Handschin, A E; Guggenheim, M; Calcagni, M; Kuenzi, W; Giovanoli, P (2010). Factor V leiden mutation and thrombotic occlusion of microsurgical anastomosis after free TRAM flap. Clinical and Applied Thrombosis/Hemostasis, 16(2):199-203.

Heimpel, H; Matuschek, A; Ahmed, M; Bader-Meunier, B; Colita, A; Delaunay, J; Garcon, L; Gilsanz, F; Goede, J; Högel, J; Kohne, E; Leichtle, R; Munoz, J; Perrotta, S; Piscopo, C; Renella, R; Schwarz, K; Smolenska-Sym, G; Wickramasinghe, S; Zanella, A; Iolascon, A (2010). Frequency of congenital dyserythropoietic anemias in Europe. European Journal of Haematology, 85(1):20-25.

Vallelian, F; Schaer, C A; Kaempfer, T; Gehrig, P; Duerst, E; Schoedon, G; Schaer, D J (2010). Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity. Blood, 116(24):5347-5356.

Schwenkglenks, M; Pettengell, R; Szucs, T D; Culakova, E; Lyman, G H (2010). Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery. Journal of Hematology and Oncology, 3:27.

Strowig, T; Chijioke, O; Carrega, P; Arrey, F; Meixlsperger, S; Rämer, P C; Ferlazzo, G; Münz, C (2010). Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood, 116(20):4158-4167.

Revel-Vilk, S; Blanchette, V S; Schmugge, M; Clark, D S; Lillicrap, D; Rand, M L (2010). In vitro and in vivo stability of diluted recombinant factor VIII for continuous infusion use in haemophilia A. Haemophilia, 16(1):72-79.

Meissner, Felix; Seger, Reinhard A; Moshous, Despina; Fischer, Alain; Reichenbach, Janine; Zychlinsky, Arturo (2010). Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood, 116(9):1570-1573.

Speer, O; Schmugge, M (2010). Investigating caspases and other markers of apoptosis in ITP. Annals of Hematology, 69(Sup 1):S45-S46.

Lee, J W; Yoon, S S; Shen, Z X; Ganser, A; Hsu, H C; Habr, D; Domokos, G; Roubert, B; Porter, J B; et al; Schmugge, M (2010). Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial. Blood, 116(14):2448-2354.

von Hoff, K; Hartmann, W; von Bueren, A O; Gerber, N U; Grotzer, M A; Pietsch, T; Rutkowski, S (2010). Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors. Pediatric Blood & Cancer, 54(3):369-376.

Douderova, D; Schneider-Yin, X; Lautenschlager, S; Saudek, V; Theiler, M; Hofbauer, G F L; Dziunycz, P J; Oyama, N; French, L E; Martasek, P; Minder, E I (2010). Lichen sclerosus et atrophicus-like skin lesions in a patient carrying a novel hydroxymethylbilane synthase mutation. Blood Cells Molecules and Diseases, 45(2):176-179.

Möricke, A; Zimmermann, M; Reiter, A; Henze, G; Schrauder, A; Gadner, H; Ludwig, W D; Ritter, J; Harbott, J; Mann, G; Klingebiel, T; Zintl, F; Niemeyer, C; Kremens, B; Niggli, F; Niethammer, D; Welte, K; Stanulla, M; Odenwald, E; Riehm, H; Schrappe, M (2010). Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia, 24(2):265-284.

Dummer, R; Hauschild, A; Guggenheim, M; Jost, L; Pentheroudakis, G (2010). Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 21(Sup. 5):v194-v197.

Conter, V; Bartram, C R; Valsecchi, M G; Schrauder, A; Panzer-Grümayer, R; Möricke, A; Aricò, M; Zimmermann, M; Mann, G; De Rossi, G; Stanulla, M; Locatelli, F; Basso, G; Niggli, F; Barisone, E; Henze, G; Ludwig, W D; Haas, O A; Cazzaniga, G; Koehler, R; Silvestri, D; Bradtke, J; Parasole, R; Beier, R; van Dongen, J J M; Biondi, A; Schrappe, M (2010). Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood, 115(16):3206-14.

Flotho, C; Batz, C; Hasle, H; Bergsträsser, E; van den Heuvel-Eibrink, M M; Zecca, M; Niemeyer, C M; Zenker, M (2010). Mutational analysis of SHOC2, a novel gene for Noonan-like syndrome, in JMML. Blood, 115(4):913.

Grisariu, S; Avni, B; Batchelor, T T; van den Bent, M J; Bokstein, F; Schiff, D; Kuittinen, O; Chamberlain, M C; Roth, P; Nemets, A; Shalom, E; Ben-Yehuda, D; Siegal, T (2010). Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood, 115(24):5005-5011.

Pichler, H; Möricke, A; Mann, G; Teigler-Schlegel, A; Niggli, F; Nebral, K; König, M; Inthal, A; Krehan, D; Dworzak, M N; Janousek, D; Harbott, J; Schrappe, M; Gadner, H; Strehl, S; Haas, O A; Panzer-Grümayer, R; Attarbaschi, A (2010). Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy. British Journal of Haematology, 149(1):93-100.

Hofmann, A; Gerrits, B; Schmidt, A; Bock, T; Bausch-Fluck, D; Aebersold, R; Wollscheid, B (2010). Proteomic cell surface phenotyping of differentiating acute myeloid leukemia cells. Blood, 116(13):e26-34.

Streif, W; Oliveri, M; Weickardt, S; Eberl, W; Knoefler, R (2010). Testing for inherited platelet defects in clinical laboratories in Germany, Austria and Switzerland. Results of a survey carried out by the Permanent Paediatric Group of the German Thrombosis and Haemostasis Research Society (GTH). Platelet, 21(6):470-478.

Matter-Walstra, K W; Dedes, K J; Schwenkglenks, M; Brauchli, P; Szucs, T D; Pestalozzi, B C (2010). Trastuzumab beyond progression: a cost-utility analysis. Annals of Oncology, 21(11):2161-2168.

2009

Trojan, A; Montemurro, M; Kamel, M; Kristiansen, G (2009). Successful PDGFR-{alpha}/{beta} targeting with imatinib in uterine sarcoma. Annals of Oncology, 20(11):1898-1899.

Avneon, M; Lifshitz, L; Katz, O; Prutchi-Sagiv, S; Gassmann, M; Mittelman, M; Neumann, D (2009). Non-erythroid effects of erythropoietin: Are neutrophils a target? Leukemia Research, 33(10):1430-1432.

Ruhstaller, T; Widmer, L; Schuller, J C; Roth, A; Hess, V; Mingrone, W; von Moos, R; Borner, M; Pestalozzi, B C; BalmerMajno, S; Köberle, D; Terraciano, L; Schnider, A; Bodis, S; Popescu, R; Swiss Group for Clinical Cancer Research (SAKK) (2009). Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of Oncology, 20(9):1522-1528.

Kingston, D; Schmid, M A; Onai, N; Obata-Onai, A; Baumjohann, D; Manz, M G (2009). The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood, 114(4):835-843.

Manz, M G (2009). Flt3L, DCs, and NTregs: team contra GVHD? Blood, 113(25):6267-6268.

Pestalozzi, B C (2009). Brain metastases and subtypes of breast cancer. Annals of Oncology, 20(5):803-805.

Pavlidis, N; Hansen, H; Stahel, R (2009). ESMO clinical recommendations: using the easier and faster approach to oncology guidelines. Annals of Oncology, 20(Suppl):7-9.

Hofer, S; Kollias, S; Weller, M (2009). Evolution of glioblastoma. Acta Oncologica, 48(4):630-631.

Stussi, G; Tichelli, A; Schanz, U; Goede, J (2009). Hypereosinophilia with a low blast count as the initial manifestation of acute myeloid leukaemia with RUNX1-RUNX1T1. British Journal of Haematology, 146(4):346.

Merad, M; Manz, M G (2009). Dendritic cell homeostasis. Blood, 113(15):3418-3427.

Tiede, A; Huth-Kühne, A; Oldenburg, J; Grossmann, R; Geisen, U; Krause, M; Brand, B; Alberio, L; Klamroth, R; Spannagl, M; Knöbl, P (2009). Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland. Annals of Hematology, 88(4):365-370.

Seifert, H; Mohr, B; Thiede, C; Oelschlägel, U; Schäkel, U; Illmer, T; Soucek, S; Ehninger, G; Schaich, M; Study Alliance Leukemia (SAL) (2009). The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia. Leukemia, 23(4):656-663.

Buehler, P W; Abraham, B; Vallelian, F; Linnemayr, C; Pereira, C P; Cipollo, J F; Jia, Y; Mikolajczyk, M; Boretti, F S; Schoedon, G; Alayash, A I; Schaer, D J (2009). Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood, 113(11):2578-2586.

Benz, R; Siciliano, R D; Stussi, G; Fehr, J (2009). Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia. European Journal of Haematology, 82(3):194-200.

Boerma, E G; Siebert, R; Kluin, P M; Baudis, Michael (2009). Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge. Leukemia, 23(2):225-234.

Hamedi, M; Belibasakis, G N; Cruchley, A T; Rangarajan, M; Curtis, M A; Bostanci, N (2009). Porphyromonas gingivalis culture supernatants differentially regulate interleukin-1beta and interleukin-18 in human monocytic cells. Cytokine, 45(2):99-104.

Muetze, S; Eggermann, T; Leeners, B; Birke, C; Kuse, S; Ortlepp, J R; Rudnik-Schoeneborn, S; Zerres, K; Rath, W (2009). The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with HELLP syndrome. Journal of Thrombosis and Thrombolysis, 27(2):141-145.

Stussi, G; Halter, J; Bucheli, E; Valli, P V; Seebach, L; Gmür, J; Gratwohl, A; Passweg, J R; Seebach, J D (2009). Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins. Haematologica, 94(2):239-248.

Zenhaeusern, G; Gubser, P; Eisele, P; Gasser, O; Steinhuber, A; Trampuz, A; Handschin, C; Luster, A D; Hess, C (2009). A high-mobility, low-cost phenotype defines human effector-memory CD8+ T cells. Blood, 113(1):95-99.

Hermann, F; Enseleit, F; Spieker, L; Periat, D; Sudano, I; Hermann, M; Corti, R; Noll, G; Ruschitzka, F; Lüscher, Thomas F (2009). Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia. Thrombosis Research, 123(3):460-465.

Hitz, F; Martinelli, G; Zucca, E; von Moos, R; Mingrone, W; Simcock, M; Peterson, J; Cogliatti, S B; Bertoni, F; Zimmermann, D R; Ghielmini, M (2009). A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03. Hematological Oncology, 27(3):154-159.

Hochuli, M; Zurbriggen, K; Schmid, M; Speer, O; Rochat, P; Frauchiger, B; Kleinert, P; Schmugge, M; Troxler, H (2009). A new alpha-globin variant with increased oxygen affinity in a Swiss family: Hb Frauenfeld [alpha 138(H21)Ser-->Phe, TCC>TTC (alpha 2)]. Hemoglobin, 33(1):54-58.

Gogas, H; Eggermont, A M M; Hauschild, A; Hersey, P; Mohr, P; Schadendorf, D; Spatz, A; Dummer, R (2009). Biomarkers in melanoma. Annals of Oncology, 20(Suppl):vi8-vi13.

Rabaglio, M; Sun, Z; Price, K N; Castiglione-Gertsch, M; Hawle, H; Thürlimann, B; Mouridsen, H; Campone, M; Forbes, J F; Paridaens, R J; Colleoni, M; Pienkowski, T; Nogaret, J M; Láng, I; Smith, I; Gelber, R D; Goldhirsch, A; Coates, A S (2009). Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial. Annals of Oncology, 20(9):1489-1498.

Kataru, R P; Jung, K; Jang, C; Yang, H; Schwendener, R; Baik, J E; Han, S H; Alitalo, K; Koh, G Y (2009). Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood, 113(22):5650-5659.

Dummer, R; Hauschild, A; Pentheroudakis, G (2009). Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 20(Suppl 4):iv129-iv131.

Ceppi, Francesco; Brown, Angela; Betts, David R; Niggli, Felix; Beck Popovic, Maja (2009). Cytogenetic characterization of childhood acute lymphoblastic leukemia in Nicaragua. Pediatric Blood & Cancer, 53(7):1238-1241.

Riesterer, O; Mason, K A; Raju, U; Yang, Q; Wang, L; Hittelman, W N; Ang, K K; Milas, L (2009). Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed. Radiotherapy and Oncology, 92(3):383-387.

Zurbriggen, K; Schmid, M; Schmugge, M; Troxler, H; Speer, O (2009). Hb Alperton [beta135(H13)Ala-->Val] shows decreased oxygen affinity. Hemoglobin, 33(6):498-502.

Lang, P A; Cervantes-Barragan, L; Verschoor, A; Navarini, A A; Recher, M; Pellegrini, M; Flatz, L; Bergthaler, A; Honda, K; Ludewig, B; Ohashi, P S; Lang, K S (2009). Hematopoietic cell-derived interferon controls viral replication and virus-induced disease. Blood, 113(5):1045-1052.

Pachlopnik Schmid, Jana; Moshous, D; Boddaert, N; Neven, B; Dal Cortivo, L; Tardieu, M; Cavazzana-Calvo, M; Blanche, S; de Saint Basile, G; Fischer, A (2009). Hematopoietic stem cell transplantation in Griscelli syndrome type 2: a single-center report on 10 patients. Blood, 114(1):211-218.

Giro, C; Berger, B; Bölke, E; Ciernik, I F; Duprez, F; Locati, L; Maillard, S; Ozsahin, M; Pfeffer, R; Robertson, A G; Langendijk, J A; Budach, W (2009). High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes. Radiotherapy and Oncology, 90(2):166-171.

Clifford, G M; Rickenbach, M; Lise, M; Dal Maso, L; Battegay, M; Bohlius, J; Boffi El Amari, E; Karrer, Urs; Jundt, G; Bordoni, A; Ess, S; Franceschi, S (2009). Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood, 113(23):5737-5742.

Mosnier, L O; Zampolli, A; Kerschen, E J; Schuepbach, R A; Banerjee, Y; Fernández, J A; Yang, X V; Riewald, M; Weiler, H; Ruggeri, Z M; Griffin, J H (2009). Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant. Blood, 113(23):5970-5978.

Düber, S; Hafner, M; Krey, M; Lienenklaus, S; Roy, B; Hobeika, E; Reth, M; Buch, T; Waisman, A; Kretschmer, K; Weiss, S (2009). Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells. Blood, 114(24):4960-4967.

Dindo, D; Breitenstein, S; Hahnloser, D; Seifert, Burkhardt; Yakarisik, S; Asmis, L M; Muller, M K; Clavien, P A (2009). Kinetics of D-dimer after general surgery. Blood Coagulation and Fibrinolysis, 20(5):347-352.

Rostock, M; Saller, R (2009). Komplementäre Therapieverfahren in der Onkologie Homöopathie. Onkologe, 15(12):1243-1250.

Zenhäusern, R; Von Rohr, A; Rufibach, K; Solenthaler, Max; Meyer-Monard, S; Gratwohl, A; Hess, U; Bargetzi, M J; Kovacsovic, T; Leoncini, L; Tobler, A (2009). Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia - a multicentre trial SAKK 32/95. Leukemia and Lymphoma, 50(1):133-136.

Stahel, R A; Weder, W; Felip, E (2009). Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 20(Suppl):73-75.

Loh, M L; Sakai, D S; Flotho, C; Kang, M; Fliegauf, M; Archambeault, S; Mullighan, C G; Chen, L; Bergstraesser, E; Bueso-Ramos, C E; Emanuel, P D; Hasle, H; Issa, J P; van den Heuvel-Eibrink, M M; Locatelli, F; Stary, J; Trebo, M; Wlodarski, M; Zecca, M; Shannon, K M; Niemeyer, C M (2009). Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood, 114(9):1859-1863.

Wasik, J S; Simon, R W; Meier, T; Steinmann, B; Amann-Vesti, B R (2009). Nailfold capillaroscopy: Specific features in Fabry disease. Clinical Hemorheology and Microcirculation, 42(2):99-106.

Meyer, C; Kowarz, E; Hofmann, J; Renneville, A; Zuna, J; Trka, J; Ben Abdelali, R; Macintyre, E; De Braekeleer, E; De Braekeleer, M; Delabesse, E; de Oliveira, M P; Cavé, H; Clappier, E; van Dongen, J J M; Balgobind, B V; van den Heuvel-Eibrink, M M; Beverloo, H B; Panzer-Grümayer, R; Teigler-Schlegel, A; Harbott, J; Kjeldsen, E; Schnittger, S; Koehl, U; Gruhn, B; Heidenreich, O; Chan, L C; Yip, S F; Krzywinski, M; Eckert, C; Möricke, A; Schrappe, M; Alonso, C N; Schäfer, B W; Krauter, J; Lee, D A; Zur Stadt, U; Te Kronnie, G; Sutton, R; Izraeli, S; Trakhtenbrot, L; Lo Nigro, L; Tsaur, G; Fechina, L; Szczepanski, T; Strehl, S; Ilencikova, D; Molkentin, M; Burmeister, T; Dingermann, T; Klingebiel, T; Marschalek, R (2009). New insights to the MLL recombinome of acute leukemias. Leukemia, 23(8):1490-1499.

Menke, M N; Feke, G T; McMeel, J W; Treon, S P (2009). Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia. Clinical Lymphoma and Myeloma, 9(1):100-103.

Willemze, R; Dreyling, M (2009). Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 20(Suppl.):iv115-iv118.

Zehnder, A; Fisch, U; Hirt, A; Niggli, F K; Simon, A; Ozsahin, H; Schlapbach, L J; Ammann, R A (2009). Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose-binding lectin-associated serine protease-2 (MASP-2). Pediatric Blood & Cancer, 53(1):53-57.

Schuepbach, R A; Feistritzer, C; Fernández, J A; Griffin, J H; Riewald, M (2009). Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1. Thrombosis and Haemostasis, 101(4):724-733.

Schiferer, A; Panzer, S; Reesink, H W; Baulig, W; Bélisle, S; Gerrard, C; Grubitzsch, H; von Heymann, C; Isetta, C; Janvier, G; Kastrup, M; Lassnigg, A; Lehot, J J; Raivio, P; Schmid, E R; Schmidlin, D; Suojaranta-Ylinen, R; Vuylsteke, A; Westerlind, A; Zuckermann, A; Hiesmayr, M (2009). Red cell transfusion in elective cardiac surgery patients. Vox Sanguinis, 97(2):172-182.

Bianchi, M; Hakkim, A; Brinkmann, V; Siler, U; Seger, R A; Zychlinsky, A; Reichenbach, J (2009). Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood, 114(13):2619-2622.

Laubli, H; Spanaus, K; Borsig, L (2009). Selectin-mediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes. Blood, 114(20):4583-4591.

Paioni, P; Kroiss, S; Kägi, E; Bergsträsser, E; Fasnacht, M; Bauersfeld, U; Schmugge, M; Albisetti, M (2009). Self-monitoring of oral anticoagulation therapy in children. Acta Haematologica, 122(1):58-63.

Hersey, P; Bastholt, L; Chiarion-Sileni, V; Cinat, G; Dummer, R; Eggermont, A M M; Espinosa, E; Hauschild, A; Quirt, I; Robert, C; Schadendorf, D (2009). Small molecules and targeted therapies in distant metastatic disease. Annals of Oncology, 20(Suppl):vi35-vi40.

Merlini, L; Hanquinet, S; Güngör, Tayfun; Ozsahin, H (2009). Spontaneous thrombosis of hepatic aneurysms in an infant with Wiskott-Aldrich syndrome. Pediatric Hematology-Oncology, 26(4):261-266.

McCann, S; Schwenkglenks, M; Bacon, P; Einsele, H; D'Addio, A; Maertens, J; Niederwieser, D; Rabitsch, W; Roosaar, A; Ruutu, T; Schouten, H; Stone, R; Vorkurka, S; Quinn, B; Blijlevens, N (2009). The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone Marrow Transplantation, 43(2):141-147.

Baenziger, S; Heikenwalder, M; Johansen, P; Schlaepfer, E; Hofer, U; Miller, R C; Diemand, S; Honda, K; Kundig, T M; Aguzzi, A; Speck, R F (2009). Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood, 113(2):377-388.

2008

LeibundGut-Landmann, Salomé; Osorio, F; Brown, G D; Reis e Sousa, C (2008). Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood, 112(13):4971-4980.

Blyszczuk, P; Valaperti, A; Eriksson, U (2008). Future therapeutic strategies in inflammatory cardiomyopathy: insights from the experimental autoimmune myocarditis model. Cardiovascular and Hematolgical Disorders, 8(4):297-305.

Pettengell, R; Bosly, A; Szucs, T D; Jackisch, C; Leonard, R; Paridaens, R; Constenla, M; Schwenkglenks, M (2008). Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study. British Journal of Haematology, 144(5):677-685.

Zehnder, L; Schulzki, T; Goede, J S; Hayes, J; Reinhart, W H (2008). Erythrocyte storage in hypertonic (SAGM) or isotonic (PAGGSM) conservation medium: influence on cell properties. Vox Sanguinis, 95(4):280-287.

Pestalozzi, B C; et al; Gelber, R D; Viale, G (2008). Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial. Annals of Oncology, 19(11):1837-1841.

Stahel, R A (2008). Educational book of the 33rd ESMO Congress Stockholm, Sweden 12-16 September 2008. Introduction. Annals of Oncology, 19 Sup:vii22.

Asmis, L M; Segal, J B; Plantinga, L C; Fink, N E; Kerman, J S; Kickler, T S; Coresh, J; Gardner, L B (2008). Heparin-induced antibodies and cardiovascular risk in patients on dialysis. Thrombosis and Haemostasis, 100(3):498-504.

Weder, W (2008). Lung cancer: new opportunities - changing algorithm in staging. Annals of Oncology, 19(Suppl):vii28-vii30.

Dooley, Kimberly A; Fraenkel, Paula G; Langer, Nathaniel B; Schmid, Bettina; Davidson, Alan J; Weber, Gerhard; Chiang, Ken; Foott, Helen; Dwyer, Caitlin; Wingert, Rebecca A; Zhou, Yi; Paw, Barry H; Zon, Leonard I (2008). montalcino, A zebrafish model for variegate porphyria. Experimental Hematology, 36(9):1132-1142.

Tun-Kyi, A; Qin, J Z; Oberholzer, P A; Navarini, A A; Hassel, J C; Dummer, R; Döbbeling, U (2008). Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model. Annals of Oncology, 19(8):1488-1494.

Gruber, G; Cole, B F; Castiglione-Gertsch, M; et al; Stahel, R (2008). Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer. Annals of Oncology, 19(8):1393-1401.

Borner, M; Koeberle, D; Von Moos, R; Saletti, P; Rauch, D; Hess, V; Trojan, A; Helbling, D; Pestalozzi, B; Caspar, Christian; Ruhstaller, T; Roth, A; Kappeler, A; Dietrich, D; Lanz, D; Mingrone, W (2008). Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the swiss group for clinical cancer research SAKK. Annals of Oncology, 19(7):1288 -1292.

Benz, R; Goede, J S; Parlier, V; Mühlematter, D; Jotterand, M; Fehr, J (2008). G-CSF-induced remission in two cases of acute myeloid leukemia. Leukemia Research, 32(7):1148-1152.

Garbe, C; Radny, P; Linse, R; Dummer, R; Gutzmer, R; Ulrich, J; Stadler, R; Weichenthal, M; Eigentler, T K; Ellwanger, U; Hauschild, A (2008). Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis. Annals of Oncology, 19(6):1195-1201.

Kistler, U; Kramers-de Quervain, I; Munzinger, U; Kucher, N (2008). Bleeding complications after systematic switch of routine thromboprophylaxis for major orthopaedic surgery. Thrombosis and Haemostasis, 99(6):1049-1052.

Golling, P; Cozzio, A; Dummer, R; French, L; Kempf, W (2008). Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome. Leukemia and Lymphoma, 49(6):1094-1103.

Worthley, S G; Helft, G; Corti, R; Worthley, M I; Chew, D P; Fayad, Z A; Zaman, A G; Fallon, J T; Fuster, V; Badimon, J J (2008). Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis. Pathophysiology of Haemostasis and Thrombosis, 36(1):9-17.

Krafft, A; Asmis, L M; Zimmermann, R (2008). Treatment of midgestational placental haemorrhage with recombinant factor VIIa. Thrombosis and Haemostasis, 100(1):154-155.

Pestalozzi, B; Castiglione, M; ESMO Guidelines Working Group (2008). Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 19(Suppl 2):ii7-ii10.

Dummer, R; Hauschild, A; Jost, L (2008). Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 19(Suppl):ii86-ii88.

Dummer, R; Dreyling, M (2008). Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 19(Suppl):ii72-ii76.

Contassot, E; Kerl, K; Roques, S; Shane, R; Gaide, O; Dupuis, M; Rook, A H; French, L E (2008). Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression. Blood, 111(9):4780-4787.

Spieth, K; Kaufmann, R; Dummer, R; Garbe, C; Becker, J C; Hauschild, A; Tilgen, W; Ugurel, S; Beyeler, M; Bröcker, E B; Kaehler, K C; Pföhler, C; Gille, J; Leiter, U; Schadendorf, D (2008). Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the dermatologic cooperative oncology group (DeCOG). Annals of Oncology, 19(4):801-806.

Curioni-Fontecedro, A; Knights, A J; Tinguely, M; Nuber, N; Schneider, C; Thomson, C W; von Boehmer, Lisa; Bossart, W; Pahlich, S; Gehring, H; Moch, H; Renner, C; Knuth, A; Zippelius, A (2008). MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma. Leukemia, 22(8):1646-1648.

Szucs, T D (2008). Can we afford the war on cancer? Onkologie, 31(3):81.

Frost, D W; Trkola, A; Günthard, H F; Richman, D D (2008). Antibody responses in primary HIV-1 infection. Current Opinion in HIV and AIDS, 3(1):45-51.

Bernier, J; Bonner, J; Vermorken, J B; Bensadoun, R J; Dummer, R; Giralt, J; Kornek, G; Hartley, A; Mesia, R; Robert, C; Segaert, S; Ang, K K (2008). Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Annals of Oncology, 19(1):142-149.

Betts, D R; Stanchescu, R; Niggli, F K; Cohen, N; Rechavi, G; Amariglio, N; Trakhtenbrot, L (2008). SKY reveals a high frequency of unbalanced translocations involving chromosome 6 in t(12;21)-positive acute lymphoblastic leukemia. Leukemia Research, 32(1):39-43.

Zhao, J; Moch, H (2008). Absence of JH2 domain mutation of the tyrosine kinase JAK2 in renal cell carcinomas. Acta Oncologica, 47(3):474-476.

Schuepbach, Reto A; Feistritzer, Clemens; Brass, Lawrence F; Riewald, Matthias (2008). Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin. Blood, 111(5):2667-2673.

Malinge, S; Ragu, C; Della-Valle, V; Pisani, D; Constantinescu, S N; Perez, C; Villeval, J-l; Reinhardt, D; Landman-Parker, J; Michaux, L; Dastugue, N; Baruchel, A; Vainchenker, W; Bourquin, J-P; Penard-Lacronique, V; Bernard, O A (2008). Activating mutations in human acute megakaryoblastic leukemia. Blood, 112(10):4220-4226.

Teuffel, O; Stanulla, M; Cario, G; Ludwig, W D; Rottgers, S; Schafer, B W; Zimmermann, M; Schrappe, M; Niggli, F K (2008). Anemia and survival in childhood acute lymphoblastic leukemia. Haematologica, 93(11):1652-7.

Szucs, T D; Dedes, K J (2008). Balancing costs and benefits in cancer therapy and prevention. Annals of Oncology, 19(Suppl.):vii313-vii319.

Kucher, N; Spirk, D; Kalka, C; Mazzolai, L; Nobel, D; Banyai, M; Frauchiger, B; Bounameaux, H (2008). Clinical predictors of prophylaxis use prior to the onset of acute venous thromboembolism in hospitalized patients SWIss Venous ThromboEmbolism Registry (SWIVTER). Journal of Thrombosis and Haemostasis, 6(12):2082-2087.

Frischknecht, H; Troxler, H; Greiner, J; Hengartner, H; Dutly, F (2008). Compound heterozygosity for Hb S [beta6(A3)GluVal, GAG-->GTG] and a new thalassemic mutation [beta132(H10)Lys-->term, AAA-->TAA] detected in a family from West Africa. Hemoglobin, 32(3):309-313.

Wiegering, V A; Kellenberger, C J; Bodmer, N; Bergstraesser, E; Niggli, F K; Grotzer, M A; Nadal, D; Bourquin, J P (2008). Conservative management of acute appendicitis in children with hematologic malignancies during chemotherapy-induced neutropenia. Journal of Pediatric Hematology/Oncology, 30(6):464-467.

Oehler-Jänne, C; Taverna, C; Stanek, N; Negretti, L; Lütolf, U M; Ciernik, I F (2008). Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma: a case-control study. Hematological Oncology, 26(2):82-90.

Kim, D D; Miwa, T; Kimura, Y; Schwendener, R; van Lookeren Campagne, M; Song, W C (2008). Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg. Blood, 112(4):1109-1119.

Muñoz, M; Breymann, C; García-Erce, J A; Gómez-Ramírez, S; Comin, J; Bisbe, E (2008). Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sanguinis, 94(3):172-183.

Templin, C; Kotlarz, D; Rathinam, C; Rudolph, C; Schätzlein, S; Ramireddy, K; Rudolph, K L; Schlegelberger, B; Klein, C; Drexler, H (2008). Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin. Experimental Hematology, 36(2):204-215.

Flotho, C; Kratz, C P; Bergsträsser, E; Hasle, H; Starý, J; Trebo, M; van den Heuvel-Eibrink, M M; Wójcik, D; Zecca, M; Locatelli, F; Niemeyer, C M (2008). Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations. Blood, 111(2):966-7; author reply 967.

Pentheroudakis, G; Stahel, R; Hansen, H; Pavlidis, N (2008). Heterogeneity in cancer guidelines: should we eradicate or tolerate? Annals of Oncology, 19(12):2067-2078.

Spring, S; Simon, R; van der Loo, B; Kovacevic, T; Brockes, C; Rousson, V; Amann-Vesti, B; Koppensteiner, R (2008). High-dose atorvastatin in peripheral arterial disease (PAD): Effect on endothelial function, intima-media-thickness and local progression of PAD - An open randomized controlled pilot trial. Thrombosis and Haemostasis, 99(1):182-189.

Bolinger, B; Krebs, P; Tian, Y; Engeler, D; Scandella, E; Miller, S; Palmer, D C; Restifo, N P; Clavien, P A; Ludewig, B (2008). Immunologic ignorance of vascular endothelial cells expressing minor histocompatibility antigen. Blood, 111(9):4588-4595.

Poretti, A; Zehnder, D; Boltshauser, E; Grotzer, M A (2008). Long-term complications and quality of life in children with intraspinal tumors. Pediatric Blood & Cancer, 50(4):844-848.

Ozsahin, H; Cavazzana-Calvo, M; Notarangelo, L D; Schulz, A; Thrasher, A J; Mazzolari, E; Slatter, M A; Le Deist, F; Blanche, S; Veys, P; Fasth, A; Bredius, R; Sedlacek, P; Wulffraat, N; Ortega, J; Heilmann, C; O'Meara, A; Wachowiak, J; Kalwak, K; Matthes-Martin, S; Güngör, Tayfun; Ikinciogullari, A; Landais, P; Cant, A J; Friedrich, W; Fischer, A (2008). Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood, 111(1):439-445.

Stahel, R A; Weder, W; Felip, E (2008). Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 19(Suppl):ii43-ii44.

Flohr, T; Schrauder, A; Cazzaniga, G; Panzer-Grümayer, R; van der Velden, V; Fischer, S; Stanulla, M; Basso, G; Niggli, F K; Schäfer, B W; Sutton, R; Koehler, R; Zimmermann, M; Valsecchi, M G; Gadner, H; Masera, G; Schrappe, M; van Dongen, J J M; Biondi, A; Bartram, C R (2008). Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia, 22(4):771-782.

Seger, R A (2008). Modern management of chronic granulomatous disease. British Journal of Haematology, 140(3):255-266.

D'Addario, G; Rauch, D; Stupp, R; Pless, M; Stahel, R; Mach, N; Jost, L; Widmer, L; Tapia, C; Bihl, M; Mayer, M; Ribi, K; Lerch, S; Bubendorf, L; Betticher, D C (2008). Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03. Annals of Oncology, 19(4):739-745.

Bodmer, N; Walters, D K; Fuchs, B (2008). Pemetrexed, a multitargeted antifolate drug, demonstrates lower efficacy in comparison to methotrexate against osteosarcoma cell lines. Pediatric Blood & Cancer, 50(4):905-908.

Regan, M M; Pagani, O; Walley, B; et al; Stahel, R A (2008). Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy? Annals of Oncology, 19(7):1231-1241.

Nieländer, I; Martín-Subero, J I; Wagner, F; Baudis, Michael; Gesk, S; Harder, L; Hasenclever, D; Klapper, W; Kreuz, Markus; Pott, C; Martinez-Climent, J A; Dreyling, M; Arnold, N; Siebert, R (2008). Recurrent loss of the Y chromosome and homozygous deletions within the pseudoautosomal region 1: association with male predominance in mantle cell lymphoma. Haematologica, 93(6):949-950.

Turello, R; Rentsch, K; Di Paolo, E; Beck Popovic, M (2008). Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism. Pediatric Blood & Cancer, 50(1):154-156.

Riesterer, O; Gmür, J; Lütolf, U (2008). Repeated and preemptive palliative radiotherapy of symptomatic hepatomegaly in a patient with advanced myelofibrosis. Onkologie, 31(6):325-327.

Gianella, S; Schaer, D J; Schwarz, U; Kurrer, M; Heppner, F L; Fehr, J; Seebach, J D (2008). Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still's disease and concurrent macrophage activation syndrome. American Journal of Hematology, 83(5):424-427.

Möricke, A; Reiter, A; Zimmermann, M; Gadner, H; Stanulla, M; Dördelmann, N; Löning, L; Beier, R; Ludwig, W D; Ratei, R; Harbott, J; Boos, H; Mann, G; Niggli, F; Feldges, A; Henze, G; Welte, K; Beck, J D; Klingebiel, T; Niemeyer, C; Zintl, F; Bode, U; Urban, C; Wehinger, H; Niethammer, D; Riehm, H; Schrappe, M (2008). Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood, 111(9):4477-4489.

Schmugge, M; Waye, J S; Basran, R K; Zurbriggen, K; Frischknecht, H (2008). THE Hb S/beta+ -thalassemia phenotype demonstrates that the IVS-I (-2) (A>C) mutation is a mild beta-thalassemia allele. Hemoglobin, 32(3):303-307.

Gurer, C; Strowig, T; Brilot, F; Pack, M; Trumpfheller, C; Arrey, F; Park, C G; Steinman, R M; Münz, C (2008). Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood, 112(4):1231-1239.

Ravaioli, A; Monti, F; Regan, M M; Maffini, F; Mastropasqua, M G; Spataro, V; Castiglione-Gertsch, M; Panzini, I; Gianni, L; Goldhirsch, A; Coates, A; Price, K N; Gusterson, B A; Viale, G (2008). p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of Oncology, 19(4):660-668.

Pani, E; Ferrari, S (2008). p38MAPK delta controls c-Myb degradation in response to stress. Blood Cells Molecules and Diseases, 40(3):388-394.

2007

Dürig, J; Bug, S; Klein-Hitpass, L; Boes, T; Jöns, T; Martin-Subero, J I; Harder, L; Baudis, Michael; Dührsen, U; Siebert, R (2007). Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32). Leukemia, 21(10):2153-2163.

Stahel, R (2007). Adenocarcinoma, a molecular perspective. Annals of Oncology, 18(Suppl 9):ix147-ix149.

Weder, W; Stahel, R; Bernhard, J; Bodis, S; Vogt, P; Ballabeni, P; Lardinois, D; Betticher, D; Schmid, R; Stupp, R; Ris, H; Jermann, M; Mingrone, W; Roth, A; Spiliopoulos, A (2007). Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Annals of Oncology, 18(7):1196-1202.

Borsig, L (2007). Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis. Seminars in Thrombosis and Hemostasis, 33(5):540-546.

Bogdanova, A; Mihov, D; Lutz, H; Saam, B; Gassmann, M; Vogel, J (2007). Enhanced erythro-phagocytosis in polycythemic mice overexpressing erythropoietin. Blood, 110(2):762-769.

Pavlidis, N; Hansen, H; Stahel, R (2007). ESMO clinical recommendations: a practical guide for medical oncologists. Annals of Oncology, 18(11):1759-1763.

Margulies, A; Bigler-Perrotin, L; Willems Cavalli, Y; Bachmann-Mettler, I (2007). Orale Mukositis bei Patienten unter Tumortherapie. Der Onkologe, 13(4):350-355.

Pruschy, M (2007). Neue Konzepte und Substanzen zur Radiosensibilisierung. Der Onkologe, 13(3):263-268.

Goede, Jeroen S; Misselwitz, Benjamin; Taverna, Christian; Schanz, Urs; Dispenzieri, Angela; Hummel, Yvonne; Trüeb, Ralph M; Fehr, Jörg (2007). Necrobiotic xanthogranuloma successfully treated with autologous stem cell transplantation. Annals of Hematology, 86(4):303-306.

Souabni, Abdallah; Jochum, Wolfram; Busslinger, Meinrad (2007). Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus. Blood, 109(1):281-289.

Dedes, K J; Szucs, T D; Imesch, P; Fedier, A; Fehr, M K; Fink, D (2007). Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial. Annals of Oncology, 18(9):1493-1499.

Stevenson, J L; Varki, A; Borsig, L (2007). Heparin attenuates metastasis mainly due to inhibition of P- and L-selectin, but non-anticoagulant heparins can have additional effects. Thrombosis Research, 120(Suppl):S107-S111.

Köditz, J; Nesper, J; Wottawa, M; Stiehl, D P; Camenisch, G; Franke, C; Myllyharju, J; Wenger, R H; Katschinski, D M (2007). Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood, 110(10):3610-3617.

Hönig, Manfred; Albert, Michael H; Schulz, Ansgar; et al; Güngör, Tayfun (2007). Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications. Blood, 109(8):3595-3602.

Ponzoni, M; et al (2007). Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas. British Journal of Haematology, 138(3):316-323.

Thomale, U W; Bender, M; Casalis, P; Rupprecht, S; Griebenow, M; Neumann, K; Woiciechowsky, C; Unterberg, A W; Stover, J F (2007). Tacrolimus depresses local immune cell infiltration but fails to reduce cortical contusion volume in brain-injured rats. Immunobiology, 212(7):567-576.

Langheinrich, Alexander C; Kampschulte, Marian; Buch, Thomas; Bohle, Rainer M (2007). Vasa vasorum and atherosclerosis - Quid novi? Thrombosis and Haemostasis, 97(6):873-879.

2006

Weiss, G; Rosell, R; Fossella, F; Perry, M; Stahel, R; Barata, F; Nguyen, B; Paul, S; McAndrews, P; Hanna, N; Kelly, K; Bunn, P (2006). The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer. Annals of Oncology, 18(3):453-460.

Baudis, Michael; Prima, Victor; Tung, Yoon Han; Hunger, Stephen P (2006). ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression. Pediatric Blood & Cancer, 47(6):757-764.

Strobel, K; Schaefer, N; Renner, C; Veit-Haibach, P; Husarik, D; Koma, A; Hany, T (2006). Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients? Annals of Oncology, 18(4):658-664.

Stahel, R A (2006). Non-small cell lung cancer: second-line and beyond. Annals of Oncology, 17(Suppl 10):x97-x100.

Pestalozzi, B C; Zahrieh, D; Price, K N; Holmberg, S B; Lindtner, J; Collins, J; Crivellari, D; Fey, M F; Murray, E; Pagani, O; Simoncini, E; Castiglione-Gertsch, M; Gelber, R D; Coates, A S; Goldhirsch, A (2006). Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Annals of Oncology, 17(6):935-944.

Haussmann, Ursula; Fischer, Joachim; Eber, Stefan; Scherer, Franziska; Seger, Reinhard; Güngör, Tayfun (2006). Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy. Haematologica, 91(6):795-800.

Schadendorf, D; Ugurel, S; Schuler-Thurner, B; et al (2006). Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Annals of Oncology, 17(4):563-570.

Leyvraz, S; Zweifel, M; Jundt, G; Lissoni, A; Cerny, T; Sessa, C; Fey, M; Dietrich, D; Honegger, H P; Swiss Group for Clinical Cancer Research (SAKK) (2006). Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas. Annals of Oncology, 17(4):646-651.

Spieker, L E; Flammer, A J; Amacker, N; Sudano, I; Badimon, J J; Ruschitzka, F; Lüscher, Thomas F; Noll, G; Corti, R (2006). C-reactive protein influences shear stress-dependent platelet adhesion in patients with familiar hypercholesterolemia and coronary artery disease undergoing LDL apheresis. Thrombosis and Haemostasis, 96(4):540-542.

von Goessel, Heiko; Hossle, Johann Peter; Seger, Reinhard; Güngör, Tayfun (2006). Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene. Experimental Hematology, 34(4):528-535.

Szucs, T D; Bramkamp, M (2006). Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review. Journal of Thrombosis and Haemostasis, 4(6):1180-1185.

Dewey, Ricardo A; Díez, Inés Avedillo; Ballmaier, Matthias; Filipovich, Alexandra; Greil, Johann; Güngör, Tayfun; Happel, Christoph; Maschan, Alexey; Noyan, Fatih; Pannicke, Ulrich; Schwarz, Klaus; Snapper, Scott; Welte, Karl; Klein, Christoph (2006). Retroviral WASP gene transfer into human hematopoietic stem cells reconstitutes the actin cytoskeleton in myeloid progeny cells differentiated in vitro. Experimental Hematology, 34(9):1161-1169.

Wergin, Melanie C; Roos, Malgorzata; Inteeworn, Nathalie; Laluhovà, Dagmar; Allemann, Katrin; Kaser-Hotz, Barbara (2006). The influence of fractionated radiation therapy on plasma vascular endothelial growth factor (VEGF) concentration in dogs with spontaneous tumors and its impact on outcome. Radiotherapy and Oncology, 79(2):239-244.

2005

Weissmann, Norbert; Manz, Daniel; Buchspies, Daniela; Keller, Stephan; Mehling, Tanja; Voswinckel, Robert; Quanz, Karin; Ghofrani, Hossein A; Schermuly, Ralph T; Fink, Ludger; Seeger, Werner; Gassmann, Max; Grimminger, Friedrich (2005). Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia. Thrombosis and Haemostasis, 94(3):630-638.

Hernando, N; Biber, J; Forster, I C; Murer, H (2005). Recent advances in renal phosphate transport. Therapeutic Apheresis and Dialysis, 9(4):323-327.

Pestalozzi, B C; Luporsi-Gely, E; Jost, L M; Bergh, J (2005). ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer. Annals of Oncology, 16(suppl_1):i7-i9.

Felip, E; Stahel, R A; Pavlidis, N (2005). ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC). Annals of Oncology, 16(suppl_1):i28-i29.

Simonsson, B; Kloke, O; Stahel, R A (2005). ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of chronic myelogenous leukemia (CML). Annals of Oncology, 16(suppl_1):i52-i53.

Hallek, M; Stahel, R A; Greil, R (2005). ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia. Annals of Oncology, 16(Suppl 1):i50-i51.

Jost, L M; Kloke, O; Stahel, R A (2005). ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma. Annals of Oncology, 16(Suppl 1):i58-i59.

Jost, L M; Stahel, R A (2005). ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of relapsed large cell non-Hodgkin's lymphoma. Annals of Oncology, 16(Suppl 1):i60-i61.

Hiddemann, W; Dreyling, M; Stahel, R A (2005). Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma. Annals of Oncology, 16(suppl_1):i56-i57.

Manegold, C; Stahel, R A (2005). Minimum clinical recommendations for diagnosis, treatment and follow-up of malignant pleural mesothelioma. Annals of Oncology, 16(Suppl 1):i32-i33.

Molassiotis, A; Fernandez-Ortega, P; Pud, D; et al (2005). Use of complementary and alternative medicine in cancer patients: a European survey. Annals of Oncology, 16(4):655-663.

Quack Lötscher, Katharina C; Stiller, Ruth; Roos, Malgorzata; Zimmermann, Roland (2005). Protein Z in normal pregnancy. Thrombosis and Haemostasis, 93(4):706-709.

Herr, D; Borelli, S; Kempf, W; Trojan, A (2005). Fludarabine: risk factor for aggressive behaviour of squamous cell carcinoma of the skin? Annals of Oncology, 16(3):515-516.

Szucs, T D (2005). Medizinische Ökonomie in der Onkologie. Der Onkologe, 11(2):139-151.

De Giorgi, U; Demirer, T; Wandt, H; Taverna, C; Siegert, W; Bornhauser, M; Kozak, T; Papiani, G; Ballardini, M; Rosti, G (2005). Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience. Annals of Oncology, 16(1):146-151.

Martin, F; Linden, T; Katschinski, D M; Oehme, F; Flamme, I; Mukhopadhyay, C K; Eckhardt, K; Tröger, J; Barth, S; Camenisch, G; Wenger, R H (2005). Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood, 105(12):4613-4619.

Cesaro, Simone; Oneto, Rosi; Messina, Chiara; Gibson, Brenda E; Buzyn, Agnes; Steward, Colin; Gluckman, Eliane; Breddius, Robbert; Boogaerts, Marc; Vermylen, Christiane; Veys, Paul; Marsh, Judith; Badell, Isabel; Michel, Gerard; Güngör, Tayfun; Niethammer, Dietrich; Bordigoni, Pierre; Oswald, Cecilia; Favre, Claudio; Passweg, Jakob; Dini, Giorgio (2005). Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation. British Journal of Haematology, 131(2):231-236.

Kratz, Christian P; Niemeyer, Charlotte M; Castleberry, Robert P; Cetin, Mualla; Bergsträsser, Eva; Emanuel, Peter D; Hasle, Henrik; Kardos, Gabriela; Klein, Cornelia; Kojima, Seiji; Stary, Jan; Trebo, Monika; Zecca, Marco; Gelb, Bruce D; Tartaglia, Marco; Loh, Mignon L (2005). The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood, 106(6):2183-2185.

Fisch, T; Pury, P; Probst, N; Bordoni, A; Bouchardy, C; Frick, H; Jundt, G; De Weck, D; Perret, E; Lutz, J M (2005). Variation in survival after diagnosis of breast cancer in Switzerland. Annals of Oncology, 16(12):1882-1888.

2004

Hansen, H H; et al (2004). Recommendations for a Global Core Curriculum in Medical Oncology. Annals of Oncology, 15(11):1603-1612.

Jermann, M (2004). Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study. Annals of Oncology, 15(3):511-516.

Schuepbach, Reto A; Meili, Esther O; Schneider, Ernst; Peter, Ueli; Bachli, Esther B (2004). Lepirudin therapy for thrombotic complications in congenital afibrinogenaemia. Thrombosis and haemostasis, 91(5):1044-1046.

Spieker, L E; Ruschitzka, F; Badimon, J J; Noll, G; Corti, R (2004). Shear stress-dependent platelet function after LDL cholesterol apheresis. Thrombosis Research, 113(6):395-398.

Meier, S; Baumert, B G; Maier, T; Wellis, G; Burg, G; Seifert, Burkhardt; Dummer, R (2004). Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie, 27(2):145-149.

2003

Vavricka, Stephan R; Walter, Roland B; Irani, Sarosh; Halter, Joerg; Schanz, Urs (2003). Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusio. Annals of Hematology, 82(9):570-573.

Jung, Hans H; Hergersberg, Martin; Vogt, Marco; Pahnke, Jens; Treyer, Valerie; Röthlisberger, Benno; Kollias, Spyros S; Russo, David; Frey, Beat M (2003). McLeod phenotype associated with a XK missense mutation without hematologic, neuromuscular, or cerebral involvement. Transfusion, 43(7):928-938.

Fedier, A (2003). Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites. Annals of Oncology, 14(6):938-945.

Praus, Michael; Kettelgerdes, Gerhard; Baier, Michael; Holzhütter, Hermann-Georg; Jungblut, Peter R; Maissen, Manuela; Epple, Guido; Schleuning, Wolf-Dieter; Köttgen, Eckart; Aguzzi, Adriano; Gessner, Reinhard (2003). Stimulation of plasminogen activation by recombinant cellular prion protein is conserved in the NH$_2$-terminal fragment PrP23-110. Thrombosis and Haemostasis, 89(5):812-819.

Trojan, A (2003). Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma. Annals of Oncology, 14(3):501-502.

Gautschi, O (2003). Comment on "A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer", by C. M. Rudin et al. (Ann Oncol 2002; 13: 539-545). Annals of Oncology, 14(1):170.

Pichert, G; Bolliger, B; Buser, K; Pagani, O; Swiss Institute for Applied Cancer Research Network for Cancer P (2003). Evidence-based management options for women at increased breast/ovarian cancer risk. Annals of Oncology, 14(1):9-19.

Shibata, J H W; Hasegawa, J; Siemens, H J; Wolber, E; Dibbelt, L; Li, D; Katschinski, D M; Fandrey, J; Jelkmann, W; Gassmann, M; Wenger, R H; Wagner, K F (2003). Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood, 101(11):4416-4422.

Hofer, T; Wenger, R H; Kramer, M F; Ferreira, G C; Gassmann, M (2003). Hypoxic up-regulation of erythroid 5-aminolevulinate synthase. Blood, 101(1):348-350.

Corbacioglu, Selim; Eber, Stefan; Güngör, Tayfun; Hummerjohann, Jorg; Niggli, Felix (2003). Induction of Long-Term Remission of a Relapsed Childhood B–Acute Lymphoblastic Leukemia With Rituximab Chimeric Anti-CD20 Monoclonal Antibody and Autologous Stem Cell Transplantation. Journal of Pediatric Hematology/Oncology, 25(4):327-329.

2002

Bombeli, T; Jutzi, M; De Conno, E; Seifert, Burkhardt; Fehr, J (2002). In patients with deepvein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins. Blood Coagulation & Fibrinolysis, 13(7):577-581.

Ochsenbein-Imhof, Nadin; Ochsenbein, A F; Seifert, Burkhardt; Huch, Albert; Huch, Renate; Zimmermann, Roland (2002). Quantification of fetomaternal hemorrhage by fluorescence microscopy is equivalent to flow cytometry. Transfusion, 42(7):947-953.

Trojan, A (2002). Fusion PET-CT imaging of neurolymphomatosis. Annals of Oncology, 13(5):802-805.

Ziegler, S; Bürki, K; Skoda, R C (2002). A 2-kb c-mpl promoter fragment is sufficient to direct expression to the megakaryocytic lineage and sites of embryonic hematopoiesis in transgenic mice. Blood, 100(3):1072-1074.

Roos, Dirk; Meischl, Christof; de Boer, Martin; Simsek, Suat; Weening, Ron S; Sanal, Özden; Tezcan, Ilhan; Güngör, Tayfun; Law, S K Alex (2002). Genetic analysis of patients with leukocyte adhesion deficiency. Experimental Hematology, 30(3):252-261.

Wong, W W L; Dimitroulakos, J; Minden, M D; Penn, L Z (2002). HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia, 16(4):508-519.

Seger, R A (2002). Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood, 100(13):4344-4350.

2001

Ruprecht, Ruth M; Hofmann-Lehmann, Regina; Smith-Franklin, B A; Rasmussen, Robert A; Liska, V; Vlasak, J; Xu, W; Baba, T W; Chenine, A L; Cavacini, L A; Posner, M R; Katinger, H; Stiegler, G; Bernacky, B J; Rizvi, T A; Schmidt, R; Hill, L R; Keeling, M E; Montefiori, D C; McClure, H M (2001). Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies. Transfusion clinique et biologique, 8(4):350-358.

Dazzi, H; Kaufmann, K; Follath, F (2001). Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia. Annals of Oncology, 12(7):963-966.

Olopade, O I; Pichert, G (2001). Cancer genetics in oncology practice. Annals of Oncology, 12(7):895-908.

Nunez, Rafael; Gomes-Keller, M Alice; Schwarzwald, Colin C; Feige, Karsten (2001). Assessment of equine autoimmune thrombocytopenia (EAT) by flow cytometry. BMC Blood Disorders, 1:1.

Xia, Z; Tan, M M; Wong, W Wei-Lynn; Dimitroulakos, J; Minden, M D; Penn, L Z (2001). Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells. Leukemia, 15(9):1398-1407.

Wessendorf, S; Lichter, P; Schwänen, C; Fritz, B; Baudis, Michael; Walenta, K; Kloess, M; Döhner, H; Bentz, M (2001). Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas. Annals of Hematology, 80(S 3):B35-B37.

2000

Politopoulou, G; Seebach, J D; Schmugge, M; Schwarz, H P; Aguzzi, A (2000). Age-related expression of the cellular prion protein in human peripheral blood leukocytes. Haematologica, 85(6):580-587.

Schmugge, M; Boltshauser, E; Plüss, H J; Niggli, F K (2000). Long-term follow-up and residual sequelae after treatment for intracerebral germ-cell tumour in children and adolescents. Annals of Oncology, 11(5):527-533.

Zeilhofer, Hanns Ulrich; Schorr, W (2000). Role of interleukin-8 in neutrophil signaling. Current Opinion in Hematology, 7(3):178-182.

Wanner, R M; Spielmann, P; Stroka, D M; Camenisch, G; Camenisch, I; Scheid, A; Houck, D R; Bauer, C; Gassmann, M; Wenger, R H (2000). Epolones induce erythropoietin expression via hypoxia-inducible factor-1 alpha activation. Blood, 96(4):1558-1565.

Aguzzi, A (2000). Prion diseases, blood and the immune system: concerns and reality. Haematologica, 81(1):3-10.

1999

Kieffer, J; Winkler, G; Van Hove, L; Walsh, A; Thomann, P; Wyss, S; Eggenberger, E; Lutz, H (1999). Evaluation of the CELL-DYN® 3500 haematology instrument for the analysis of the mouse and rat blood. Comparative Haematology International, 9(2):92-106.

Brandner, S; Klein, M A; Aguzzi, A (1999). A crucial role for B cells in neuroinvasive scrapie. Transfusion Clinique et Biologique, 6(1):17-23.

Miralbell, R; Bieri, S; Huguenin, P; Feldges, A; Morin, A M; Garcia, E; Wagner, H P; Wacker, P; von der Weid, N (1999). Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma. Annals of Oncology, 10(2):239-241.

1998

Aguzzi, A; Weissmann, C (1998). Prion diseases. Haemophilia, 4(4):619-627.

Wenger, R H; Rolfs, A; Spielmann, P; Zimmermann, D R; Gassmann, M (1998). Mouse hypoxia-inducible factor-1alpha is encoded by two different mRNA isoforms: expression from a tissue-specific and a housekeeping-type promoter. Blood, 91(9):3471-3480.

Pichert, G; Schmitter, D; Widmer, L; Jost, L M; Kurrer, M O; Maurer, R; Stahel, R A (1998). Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin's lymphomas. Annals of Oncology, 9(1):51-54.

1997

Jost, L M; Widmer, L; Honegger, H P; Stahel, R A (1997). Index of pretreatment intensity predicts outcome of high-dose chemotherapy and autologous progenitor cell transplantation in chemosensitive relapse of Hodgkin's disease. Annals of Oncology, 8(8):785-790.

Manegold, C; Bergman, B; Chemaissani, A; Dornoff, W; Drings, P; Kellokumpu-Lehtinen, P; Liippo, K; Mattson, K; et al (1997). Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer. Annals of Oncology, 8(6):525-529.

Ozsahin, H; Arredondo-Vega, F X; Santisteban, I; Fuhrer, H; Tuchschmid, P; Jochum, W; Aguzzi, A; Lederman, H M; Fleischman, A; Winkelstein, J A; Seger, R A; Hershfield, M S (1997). Adenosine deaminase deficiency in adults. Blood, 89(8):2849-2855.

Nielsen, P J; Lorenz, B; Müller, A M; Wenger, R H; Brombacher, F; Simon, M; von der Weid, T; Langhorne, W J; Mossmann, H; Köhler, G (1997). Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice. Blood, 89(3):1058-1067.

Jaffe, E S; Burg, G (1997). Report of the Symposium on Cutaneous Lymphomas: Sixth International Conference on Malignant Lymphoma. Annals of Oncology, 8(Suppl 1):S83-S84.

Frankenberger, M; Hofmann, B; Emmerich, B; Nerl, C; Schwendener, R; Ziegler-Heitbrock, H W (1997). Liposomal 1,25 (OH)2 vitamin D3 compounds block proliferation and induce differentiation in myelomonocytic leukaemia cells. British Journal of Haematology, 98(1):186-194.

Gutzwiller, Felix (1997). Vorwort. In: Gutzwiller, Felix; Stähli, Roland; Somogyi, Pia. Gesundheit für alle : Ziele zur Gesundheitspolitik für die Schweiz. Basel: Birkhäuser, 1-2.